<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">74326</article-id><article-id pub-id-type="doi">10.7554/eLife.74326</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Protein visualization and manipulation in <italic>Drosophila</italic> through the use of epitope tags recognized by nanobodies</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-256818"><name><surname>Xu</surname><given-names>Jun</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7963-0253</contrib-id><email>Jun_Xu@hms.harvard.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-256819"><name><surname>Kim</surname><given-names>Ah-Ram</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9597-6759</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-256820"><name><surname>Cheloha</surname><given-names>Ross W</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256821"><name><surname>Fischer</surname><given-names>Fabian A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256822"><name><surname>Li</surname><given-names>Joshua Shing Shun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256823"><name><surname>Feng</surname><given-names>Yuan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256824"><name><surname>Stoneburner</surname><given-names>Emily</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256825"><name><surname>Binari</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86659"><name><surname>Mohr</surname><given-names>Stephanie E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9639-7708</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256826"><name><surname>Zirin</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9156"><name><surname>Ploegh</surname><given-names>Hidde L</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-206206"><name><surname>Perrimon</surname><given-names>Norbert</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7542-472X</contrib-id><email>perrimon@genetics.med.harvard.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03vek6s52</institution-id><institution>Department of Genetics, Harvard Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Boston Children's Hospital and Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03vek6s52</institution-id><institution>Drosophila RNAi Screening Center, Harvard Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Howard Hughes Medical Institute</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>VijayRaghavan</surname><given-names>K</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03ht1xw27</institution-id><institution>National Centre for Biological Sciences, Tata Institute of Fundamental Research</institution></institution-wrap><country>India</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>VijayRaghavan</surname><given-names>K</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03ht1xw27</institution-id><institution>National Centre for Biological Sciences, Tata Institute of Fundamental Research</institution></institution-wrap><country>India</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>25</day><month>01</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e74326</elocation-id><history><date date-type="received" iso-8601-date="2021-09-29"><day>29</day><month>09</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-01-24"><day>24</day><month>01</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-04-17"><day>17</day><month>04</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.04.16.440240"/></event></pub-history><permissions><copyright-statement>© 2022, Xu et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Xu et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-74326-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-74326-figures-v2.pdf"/><abstract><p>Expansion of the available repertoire of reagents for visualization and manipulation of proteins will help understand their function. Short epitope tags linked to proteins of interest and recognized by existing binders such as nanobodies facilitate protein studies by obviating the need to isolate new antibodies directed against them. Nanobodies have several advantages over conventional antibodies, as they can be expressed and used as tools for visualization and manipulation of proteins in vivo. Here, we characterize two short (&lt;15aa) NanoTag epitopes, 127D01 and VHH05, and their corresponding high-affinity nanobodies. We demonstrate their use in <italic>Drosophila</italic> for in vivo protein detection and re-localization, direct and indirect immunofluorescence, immunoblotting, and immunoprecipitation. We further show that CRISPR-mediated gene targeting provides a straightforward approach to tagging endogenous proteins with the NanoTags. Single copies of the NanoTags, regardless of their location, suffice for detection. This versatile and validated toolbox of tags and nanobodies will serve as a resource for a wide array of applications, including functional studies in <italic>Drosophila</italic> and beyond.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>nanobody</kwd><kwd>short epitope tag</kwd><kwd>protein labeling</kwd><kwd>protein manipulation</kwd><kwd><italic>Drosophila</italic></kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>GM132087</award-id><principal-award-recipient><name><surname>Perrimon</surname><given-names>Norbert</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>2021R1A6A3A14039622</award-id><principal-award-recipient><name><surname>Kim</surname><given-names>Ah-Ram</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001692</institution-id><institution>Croucher Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Li</surname><given-names>Joshua Shing Shun</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Perrimon</surname><given-names>Norbert</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The in vitro and in vivo characterization of two nanobody/NanoTag pairs in the <italic>Drosophila</italic> system provides a variety of assays for protein detection and manipulation.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Conventional antibodies typically have a MW ~150–160 kDa and are composed of four polypeptides, two identical heavy chains and two identical light chains. The size and composition of conventional immunoglobulins impose limitations on their application to in vivo studies. The recent development of smaller and single-polypeptide recombinant protein binders, such as single-chain variable fragments (~25 kDa), single-domain antibodies or ‘nanobodies’ (~12–15 kDa), and designed ankyrin repeat proteins (18 kDa for five repeats), has enabled many new applications (<xref ref-type="bibr" rid="bib17">Harmansa and Affolter, 2018</xref>). These new types of recombinant binders are small and stable molecules that can be encoded in the genomes of model organisms or cells. Moreover, the coding sequences of these binders can be fused to various effector domains, making them useful as tools for imaging and for regulating the function of target proteins of interest (POIs) in vivo (<xref ref-type="bibr" rid="bib18">Helma et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Harmansa and Affolter, 2018</xref>; <xref ref-type="bibr" rid="bib1">Aguilar et al., 2019</xref>). For example, a protein binder fused to a fluorescent protein can be expressed in vivo, where it can then bind to an endogenous target protein, an epitope-tagged protein, or even a post-translational modification, thus allowing visualization of subcellular localization of the target (<xref ref-type="bibr" rid="bib17">Harmansa and Affolter, 2018</xref>; <xref ref-type="bibr" rid="bib1">Aguilar et al., 2019</xref>). This is not usually possible when using conventional antibodies, which fail to assemble in the reducing environment of the cytosol.</p><p>Among available protein binders, camelid-derived nanobodies are particularly useful, as they consist of a single monomeric variable antibody domain that is the product of selection in vivo. Nanobodies are no less specific than conventional antibodies. Given their small size, nanobodies are easy to express in <italic>Escherichia coli</italic>, either alone or fused to a fluorescent marker or enzyme. The small size of nanobodies also allows better super-resolution microscopy than antibody-based imaging (<xref ref-type="bibr" rid="bib13">Fornasiero and Opazo, 2015</xref>; <xref ref-type="bibr" rid="bib23">Mikhaylova et al., 2015</xref>; <xref ref-type="bibr" rid="bib33">Virant et al., 2018</xref>; <xref ref-type="bibr" rid="bib12">Fang et al., 2018</xref>), and enables binding to epitopes not accessible to full-length conventional antibodies. Because nanobodies are usually stable in the reducing environment of intracellular space and are encoded as a single polypeptide, nanobodies or nanobody fusion proteins can be expressed in eukaryotes and used for a number of in vivo applications (<xref ref-type="bibr" rid="bib18">Helma et al., 2015</xref>).</p><p>Nanobodies are powerful tools for manipulation of protein function and localization, as has been illustrated using nanobodies against GFP. For example, GFP-tagged proteins can be degraded using a GFP-targeting nanobody fused to an E3 ligase component, an approach that has been used for studies in <italic>Drosophila melanogaster</italic>, <italic>Caenorhabditis elegans</italic>, and <italic>Danio rerio</italic> (<xref ref-type="bibr" rid="bib7">Caussinus et al., 2011</xref>; <xref ref-type="bibr" rid="bib34">Wang et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Yamaguchi et al., 2019</xref>). GFP-tagged proteins can be re-localized using a GFP-targeting nanobody fused to sequences or domains that specify a particular subcellular localization (<xref ref-type="bibr" rid="bib15">Harmansa et al., 2015</xref>; <xref ref-type="bibr" rid="bib16">Harmansa et al., 2017</xref>). Many proteins in model organisms such as <italic>Drosophila</italic> have been tagged with GFP, suggesting general applicability of the approach. However, the fusion of a target protein with GFP is not necessarily compatible with all applications, a significant limitation of a GFP-targeted approach. GFP is a bulky (27 kDa) substituent that might affect function or localization of the tagged protein. In addition, maturation of the GFP chromophore is slow, limiting its use for the imaging of nascent proteins.</p><p>An alternative approach would be to combine conventional epitope tags with the advantages of nanobody-based targeting. Because of their small size, epitope tags are less likely than GFP to interfere with the overall structure of the tagged protein. Several nanobodies that recognize small epitope tags have been isolated, including tags known as BC2-tag, EPEA-tag, MoonTag, and ALFA-tag (<xref ref-type="bibr" rid="bib31">Traenkle et al., 2015</xref>; <xref ref-type="bibr" rid="bib11">De Genst et al., 2010</xref>; <xref ref-type="bibr" rid="bib3">Boersma et al., 2019</xref>; <xref ref-type="bibr" rid="bib29">Tanenbaum et al., 2014</xref>; <xref ref-type="bibr" rid="bib14">Götzke et al., 2019</xref>; <xref ref-type="bibr" rid="bib10">Cheloha et al., 2020</xref>). Some of these have been used to visualize and manipulate tagged proteins by changing their abundance or localization using tag-targeting nanobodies in mammalian cells (<xref ref-type="bibr" rid="bib37">Zhao et al., 2019</xref>; <xref ref-type="bibr" rid="bib32">Vigano et al., 2021</xref>). The recently developed ALFA nanobody (NbALFA) recognizes a short peptide of 13 amino acids and provides a system useful for immunoblotting, protein purification, and imaging (fixed or live cells) (<xref ref-type="bibr" rid="bib14">Götzke et al., 2019</xref>). In addition, it has been recently reported that HA frankenbody, a single-chain variable fragment engineered from anti-HA antibody, can be used for live imaging and protein degradation in vivo in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib32">Vigano et al., 2021</xref>). However, to the best of our knowledge, short linear epitope tag-specific nanobodies have yet to be applied for use in vivo in <italic>Drosophila</italic> or other multicellular organisms.</p><p>To expand the repertoire of nanobody-recognized tags (NanoTags) and corresponding nanobody tools, we characterized two NanoTags, VHH05- and 127D01-tags, and their corresponding nanobodies, NbVHH05 (<xref ref-type="bibr" rid="bib22">Ling et al., 2019</xref>) and Nb127D01 (<xref ref-type="bibr" rid="bib5">Bradley et al., 2015</xref>), for cellular and in vivo studies in <italic>Drosophila</italic>. Both nanobodies can be genetically encoded as fluorescent protein fusions (i.e. chromobodies [CBs]) that enable the detection of target proteins that carry NanoTags at N-terminal, internal or C-terminal sites. We show that these nanobodies are useful for multiplexed immunostaining, immunoblotting, and immunoprecipitation. We show that NanoTagged proteins can be manipulated by nanobodies fused to various subcellular localization signals. Moreover, in transgenic flies that overexpress NanoTagged proteins, we confirmed that the tagged proteins can be detected using GFP-tagged nanobodies expressed in vivo (i.e. with CBs) or by immunostaining. Finally, using CRISPR-based genome engineering, we generated flies with NanoTags inserted into endogenous genes. Our data show that VHH05- and 127D01-tags and their corresponding nanobodies can be used effectively for labeling and manipulating proteins, providing powerful tools for functional studies in <italic>Drosophila</italic> and other organisms.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Characterization of VHH05 and 127D01 NanoTags</title><p>We selected two nanobody/NanoTag pairs to test in <italic>Drosophila</italic>, NbVHH05/VHH05-tag and Nb127D01/127D01-tag. NbVHH05 is a 111 amino acid (aa) nanobody that recognizes a 14 aa sequence (VHH05-tag, QADQEAKELARQIS) derived from the human E2 ubiquitin-conjugating enzyme UBC6e (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>), and has a binding constant (K<sub>d</sub>) for the VHH05-tag of ~0.15 nM (<xref ref-type="bibr" rid="bib22">Ling et al., 2019</xref>). Nb127D01 is a 115 aa nanobody that binds to an extracellular portion of the human C-X-C chemokine receptor type 2 (CXCR2) (<xref ref-type="bibr" rid="bib5">Bradley et al., 2015</xref>). As the extracellular region of CXCR2 is large, we reduced the epitope-binding region to a minimal sequence of 10 aa (127D01-tag, SFEDFWKGED) (<xref ref-type="fig" rid="fig1">Figure 1C and D</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) to obtain a more versatile tag, and determined the K<sub>d</sub> of Nb127D01 to this tag to be &lt;50 nM (data not shown). Protein-protein BLAST searches with both NanoTags failed to identify fully homologous sequences in the <italic>Drosophila</italic> proteome, thus reducing the possibility of spurious cross-reactions with endogenous, untagged proteins.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>VHH05 and 127D01 NanoTag sequences and their corresponding nanobodies, and use of nanobodies as chromobodies.</title><p>(<bold>A and C</bold>) VHH05 and 127D01 were inserted at the N-terminus, internally or at the C-terminus of a protein of interest (POI). GSG denotes the linker, M is the start codon, and Stop is the stop codon. (<bold>B and D</bold>) Nanobody sequences of NbVHH05 and Nb127D01. Bolded and underlined CDR1-3 corresponds to complementarity-determining regions (CDRs). (<bold>E</bold>) Co-transfection of pAW-actin5C-NbVHH05-GFP and pAW-actin5C-VHH05-H2B-mCherry into S2<italic>R</italic>+ cells. H2B is a nuclear protein. The right most panel is GFP, the center panel is mCherry, and the rightmost is the merged image. 4′,6-Diamidino-2-phenylindole (DAPI) staining shows the nuclei. (<bold>F</bold>) Co-transfection of pAW-actin5C-NbVHH05-GFP and pAW-actin5C-CD8-VHH05-mCherry into S2<italic>R</italic>+ cells. CD8 is a cell membrane protein. (<bold>G</bold>) Co-transfection of pAW-actin5C-NbVHH05-GFP and pAW-actin5C-mito-mCherry-VHH05 into S2<italic>R</italic>+ cells. Mito-mCherry-VHH05 contains a localization signal peptide for mitochondrial outer membrane targeting. (<bold>H, I, and J</bold>) Experiments are as in E, F, and G, except that pAW-actin5C-Nb127D01-GFP and pAW-actin5C-127D01-H2B-mCherry were co-transfected.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Identification of the 127D01 epitope.</title><p>(<bold>A</bold>) Synthetic peptides corresponding to the full-length extracellular domain from C-X-C chemokine receptor type 2 (CXCR2) or fragments were synthesized by solid-phase peptide synthesis using Fmoc protection of the peptide backbone and purified by reverse-phase HPLC. (<bold>B</bold>) Peptides were used in a competitive ELISA in which soluble peptides compete for binding with a conjugate consisting of GFP fused with CXCR2 ECD immobilized on the ELISA plate. (<bold>C</bold>) Representative data from a competition ELISA experiment. Data points represent mean ± SD from duplicate experiments.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Schematic representation of the constructs and confocal images in S2R+ cells.</title><p>(<bold>A and B</bold>) Transcriptional elements promoter and SV40 of the expression vectors, the different protein coding modules are represented as colored filled boxes. (<bold>C and D</bold>) Individual transfection results of VHH05 and 127D01 vectors in S2R+ cells. Confocal images show the distribution of fluorescent proteins in the cell. DAPI staining shows the nuclei. (<bold>E</bold>) Confocal images of co-transfection of NbVHH05-GFP with different cell compartments mCherry-VHH05 vectors showed the co-localization signal of GFP and mCherry. (<bold>F</bold>) Confocal images of co-transfection of Nb127D01-GFP with different cell compartments. mCherry-127D01 vectors showed the co-localization signal of GFP and mCherry. (<bold>G</bold>) Vectors information of NbVHH05-mCherry and mito-GFP-VHH05. Confocal images of co-transfection of these two vectors showed the co-localization signal of GFP and mCherry. (<bold>H</bold>) Vector information of Nb127D01-mCherry and mito-GFP-127D01. Confocal images of co-transfection of these two vectors showed the co-localization signal of GFP and mCherry. Scale bars: 25 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig1-figsupp2-v2.tif"/></fig></fig-group><p>To determine whether these NanoTags can be used for live imaging, we visualized both the NanoTags and their corresponding nanobodies concurrently. To do this, we constructed vectors that use the <italic>Actin5c</italic> promoter to ubiquitously express mCherry proteins equipped with the NanoTags and with different cell compartment localization sequences at the N-terminus: a cell membrane localization protein (murine CD8 gene, NM_009857.1), a mitochondrial outer membrane sequence (TM domain of <italic>Homo sapiens</italic> CDGSH iron sulfur domain 1, NM_018464.5), and a nuclear localization sequence (histone H2B gene, NM_001032214.2). We also constructed vectors that ubiquitously express GFP-tagged nanobodies (NbVHH05-GFP and Nb127D01-GFP) (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A, B</xref>) under the control of the <italic>Actin5c</italic> promoter.</p><p>When expressed alone in <italic>Drosophila</italic> S2<italic>R</italic>+ cells, NanoTagged mCherry fusion proteins were observed in the expected subcellular compartments <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C, D</xref>), indicating that the VHH05- and 127D01-tags do not affect protein localization. When either NbVHH05-GFP or Nb127D01-GFP was expressed in cells, we observed a GFP signal in the nucleus and the cytoplasm, although some S2<italic>R</italic>+ cells transfected with Nb127D01-GFP contained aggregates (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C, D</xref>). Next, we co-transfected S2<italic>R</italic>+ cells with either mCherry-VHH05 fusion proteins and NbVHH05-GFP or mCherry-127D01 fusion proteins and Nb127D01-GFP. In all cases, the GFP and mCherry signals co-localized - with a distribution indistinguishable from that of mCherry fusions alone (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2E, F</xref>). We also tested whether mCherry-tagged nanobodies (NbVHH05-mCherry or Nb127D01-mCherry) co-localized with mitochondrial GFP tagged with the VHH05-tag or the 127D01-tag, respectively. As expected, we observed co-localization of NbVHH05-mCherry and mito-GFP-VHH05 when expression vectors for each were co-transfected in S2<italic>R</italic>+ cells (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2G</xref>. Similarly, Nb127D01-mCherry and mito-GFP-127D01 co-localized with mitochondria (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2H</xref>).</p><p>We next examined whether the position of the NanoTags affects recognition by the nanobodies. We generated H2B-mCherry, mito-mCherry, and CD8-mCherry with N-terminal, internal, or C-terminal NanoTags. When these vectors were co-transfected with NbVHH05-GFP or Nb127D01-GFP in S2<italic>R</italic>+ cells, GFP and mCherry co-localized with the expected cellular compartments (<xref ref-type="fig" rid="fig1">Figure 1E–J</xref>). Taken together, our data show that both NbVHH05 and Nb127D01 can be used as CBs to visualize and monitor NanoTagged proteins in their native surroundings.</p></sec><sec id="s2-2"><title>Detecting NanoTagged proteins by immunofluorescence</title><p>In addition to establishing CB-based detection of NanoTagged proteins in cells, we also explored detection by immunofluorescence. Nanobodies can be detected by either direct or indirect immunofluorescence. Direct immunofluorescence involves the use of fluorophore-conjugated nanobodies to detect the target protein(s). Indirect immunofluorescence involves recognition of the target by the nanobody, followed by detection of the nanobody recognized by a secondary fluorophore-conjugated antibody.</p><p>For direct immunofluorescence, we chemically conjugated NbVHH05 and Nb127D01 with fluorophores (NbVHH05-CF555 and Nb127D01-CF647). The success of these conjugations was confirmed by the detection of a fluorescent signal on an SDS-PAGE gel (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Immunostaining with these fluorophore-conjugated nanobodies directly revealed VHH05- and 127D01-tagged proteins in S2<italic>R</italic>+ cells (<xref ref-type="fig" rid="fig2">Figure 2A and A’</xref><bold>;</bold> <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A1, A2</xref> ). Direct immunostaining with fluorophore-conjugated nanobodies thus provides a simple and efficient method of detection. The reactivity of neither NbVHH05 nor Nb127D01 was affected by direct chemical conjugation. In addition, we used a fluorescent NbVHH05-AF555 prepared by site-specific Sortase labeling (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A3</xref>). For C-terminal Sortase-mediated labeling, the Sortase recognition motif (LPETG) is added to the C-terminus of the nanobody. Next, catalyzed by the Sortase, a fluorophore or biotin is added, using modified oligoglycine peptides such as GGG-fluorophore or GGG-biotin, to the nanobody-LPETG (<xref ref-type="bibr" rid="bib9">Cheloha et al., 2019</xref>). These chemoenzymatic reactions proceed near-quantitatively and are highly site-specific. Unlike chemical modification, the sortase labeling procedure does not entail the risk of unwanted side reactions that might otherwise affect the physicochemical properties of the final product. Because each enzymatically modified nanobody carries a single substituent (fluorophore or biotin), quantitative comparisons are in principle possible, which would be more challenging when using direct chemical conjugation.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Using NbVHH05 and Nb127D01 for immunofluorescence.</title><p>(<bold>A</bold>) Fluorophore-conjugated NbVHH05 or Nb127D01 recognizes VHH05- or 127D01-tagged fluorescence proteins. (<bold>A’</bold>) VHH05- or 127D01-tagged mito-GFP can be detected by the corresponding NbVHH05-555 or Nb127D01-647 in transfected S2<italic>R</italic>+ cells. 4′,6-Diamidino-2-phenylindole (DAPI) staining shows the nuclei. (<bold>B</bold>) Schematic of nanobodies containing ALFA-tag as primary antibody and NbALFA as a secondary antibody. (<bold>B’</bold>) VHH05- or 127D01-tagged mito-GFP can be detected using the corresponding nanobodies in transfected S2<italic>R</italic>+ cells. (<bold>C</bold>) Schematic of fluorophore-conjugated anti-Alpaca IgG antibodies to detect VHH05- and 127D01-tagged proteins. NbVHH05 or Nb127D01 is used as primary antibodies and anti-Alpaca IgG as secondary antibody. (<bold>C’</bold>) VHH05- or 127D01-tagged mito-GFP can be detected using the corresponding nanobodies and anti-Alpaca IgG-647 in transfected S2<italic>R</italic>+ cells. (<bold>D</bold>) Schematic of using VHH05 and 127D01 for double tagging. N-, C-terminal of REPTOR contains VHH05 and 127D01. (<bold>D’</bold>) Co-staining NbVHH05 and Nb127D01 in S2<italic>R</italic>+ cells transfected with VHH05-REPTOR-127D01. Scale bars: 10 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Nanobody purification and fluorophore conjugation.</title><p>(<bold>A</bold>) Fluorescence signals of NbVHH05-CF555 and Nb127D01-CF647 under 555 and 647 detection channels. (<bold>B and C</bold>) Coomassie brilliant blue staining of ALFA- and HA-tagged nanobodies purified from <italic>Escherichia coli</italic> protein expression. FT: flow-through, E1–E9: elution 1–9.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Raw data of fluorescence signals or coomassie brilliant blue staining for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-74326-fig2-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Different types of NbVHH05 and Nb127D01 and immunofluorescence examples.</title><p>(<bold>A</bold>) Direct labeling can be achieved by linking purified nanobodies with different fluorophores by antibody labeling kit or site-specifically by sortase-mediated labeling. (<bold>A1</bold>) Schematics of NbVHH05 and Nb127D01 with fluorophore-488, -555, or -647. (<bold>A2</bold>) Confocal images showing direct immunofluorescence with NbVHH05-555, NbVHH05-488, and Nb127D01-647 in S2<italic>R</italic>+ cells. (<bold>A3</bold>) Confocal images showing direct immunofluorescence with NbVHH05-555 prepared by sortase-mediated labeling. (<bold>B</bold>) Schematics of indirect labeling with nanobodies containing ALFA-tag, HA-tag, biotin, or human IgG as primary antibodies and confocal images in S2<italic>R</italic>+ cells. (<bold>B1</bold>) NbVHH05 and Nb127D01 detected with anti-VHH IgG antibody. (<bold>B2</bold>) NbVHH05 and Nb127D01 with ALFA-tag detected by NbALFA. (<bold>B3</bold>) NbVHH05 and Nb127D01 with HA-tag detected by anti-HA antibody. (<bold>B4</bold>) NbVHH05 and Nb127D01 with biotin prepared by sortase-mediated labeling detected by streptavidin. (<bold>B5</bold>) NbVHH05 and Nb127D01 with human IgG detected by anti-human IgG antibody. Scale bars: 10 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Test of potential interaction between VHH05 and 127D01.</title><p>(<bold>A</bold>) Fluorescence confocal results showed no co-localization signal. Co-transfection of Nb127D01-GFP and mito-mCherry-VHH05 or H2B-mCherry-VHH05, NbVHH05-GFP and mito-mCherry-127D01 or H2B-mCherry-127D01 in S2<italic>R</italic>+ cells. (<bold>B</bold>) Western blots indicate no cross-interaction between the two systems. Lysates from S2<italic>R</italic>+ cells transfected with different types tagged vectors (as in <xref ref-type="fig" rid="fig1">Figure 1</xref>) or a mock control plasmid were analyzed by SDS-PAGE and western blotting. The blot was developed with NbVHH05-ALFA and Nb127D01-ALFA, followed by NbALFA-HRP or a mouse anti-tubulin primary antibody, and followed by anti-mouse IgG HRP.</p><p><supplementary-material id="fig2s3sdata1"><label>Figure 2—figure supplement 3—source data 1.</label><caption><title>Raw data of Western blot for <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3b</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-74326-fig2-figsupp3-data1-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig2-figsupp3-v2.tif"/></fig></fig-group><p>To test NbVHH05 and Nb127D01 in indirect immunofluorescence, we prepared bacterially purified NbVHH05 and Nb127D01, each fused with an ALFA-tag or HA-tag. We also prepared conditioned media that contained NbVHH05 or Nb127D01 tagged with the Fc portion of human IgG (hIgG) (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B1</xref>). Likewise, we could visualize NbVHH05-hIgG and Nb127D01-hIgG using fluorescently labeled anti-hIgG antibodies (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B1</xref>). Consistent with a previous report (<xref ref-type="bibr" rid="bib14">Götzke et al., 2019</xref>), NbVHH05-ALFA and Nb127D01-ALFA can be visualized using anti-ALFA nanobodies conjugated to fluorophores (<xref ref-type="fig" rid="fig2">Figure 2</xref>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B2</xref>). We could visualize NbVHH05-HA and Nb127D01-HA using fluorescently labeled anti-HA antibodies (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B3</xref>). Next, we determined whether ALFA-, HA-, or hIgG-tagged NbVHH05 and Nb127D01 could be used as the primary reagents for indirect immunostaining. We stained S2<italic>R</italic>+ cells transfected with mito-GFP-VHH05 or mito-GFP-127D01 vectors with the corresponding primary and secondary antibodies. In both cases, the GFP signal overlapped completely with the fluorescent signal from the secondary antibody (<xref ref-type="fig" rid="fig2">Figure 2B’</xref>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>). NbVHH05 and Nb127D01 were obtained by immunization of an alpaca and llama, respectively (<xref ref-type="bibr" rid="bib22">Ling et al., 2019</xref>; <xref ref-type="bibr" rid="bib5">Bradley et al., 2015</xref>). We therefore examined whether they are both recognized by fluorophore-conjugated anti-alpaca IgG 647 which is also reactive with llama-derived nanobodies (or the VHH domain of llama IgG) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). The NanoTagged GFP and 647-fluorophore signals overlapped completely (<xref ref-type="fig" rid="fig2">Figure 2C’</xref><bold>;</bold> <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B4</xref>), indicating that commercially available secondary antibodies against llama are compatible with NbVHH05 and Nb127D01 immunostaining. In addition, we carried out indirect immunofluorescence using NbVHH05-biotin prepared by sortase labeling (<xref ref-type="bibr" rid="bib9">Cheloha et al., 2019</xref>) and obtained similar results (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B5</xref>).</p><p>The availability of two different NanoTag-nanobody pairs opens the possibility for co-staining or co-detection with CBs. To test this, we generated proteins tagged with both NanoTags (VHH05- and 127D01-tags) and used NbVHH05 and Nb127D01 fused to HA-tag or ALFA-tag with corresponding secondary antibodies for detection. Importantly, these two tagging systems operate orthogonally, as no co-localization signal was observed in cells transfected with 127D01-GFP and with H2B-mCherry-VHH05 or mito-mCherry-VHH05 (VHH05-GFP with H2B-mCherry-127D01 or mito-mCherry-127D01) (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A</xref>). To further test co-detection, we inserted VHH05 at the N-terminus of the transcription factor REPTOR and 127D01 at its C-terminus (VHH05-REPTOR-127D01). When S2<italic>R</italic>+ cells were transfected with VHH05-REPTOR-127D01, the NbVHH05-HA signal (488-fluorophore) and the Nb127D01-ALFA signal (647-fluorophore) completely overlapped (<xref ref-type="fig" rid="fig2">Figure 2D and D’</xref>). Our data show that immunostaining using both of the NanoTag-nanobody pairs can be multiplexed.</p></sec><sec id="s2-3"><title>Detection of NanoTagged proteins on immunoblots</title><p>Because the two nanobodies recognize small linear epitopes, we anticipated that these nanobodies might be useful for immunoblotting under denaturing conditions as already shown for VHH05 (<xref ref-type="bibr" rid="bib22">Ling et al., 2019</xref>). We performed immunoblotting experiments with cell lysates containing VHH05- or 127D01-tagged H2B-mCherry. Using NbVHH05-ALFA and Nb127D01-ALFA as primary nanobodies, we detected a signal using NbALFA-HRP as the secondary antibody. Using purified nanobodies at high concentrations- produced some non-specific bands. This issue was resolved by reducing the nanobody concentration - (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Next, we tested whether the two nanobodies could detect by immunoblotting proteins NanoTagged in different positions. NbVHH05 and Nb127D01 recognized proteins with internal, N- and C-terminal NanoTags on immunoblots (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). To test whether increasing the number of NanoTags improved the sensitivity of detection, we generated vectors that express secreted GFP with 1x, 2x, or 3xVHH05 or 127D01 NanoTags at the C-terminus (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). An N-terminal FLAG-tag was included in all constructs and used as the loading control. An increase in the number of NanoTags improved the sensitivity of detection using culture media that contain secreted GFP proteins (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Tagging of target proteins with more than one copy of a tag thus improves the sensitivity of detection.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Detection of NanoTagged target proteins by western blotting and immunoprecipitation.</title><p>(<bold>A</bold>) Lysates from S2<italic>R</italic>+ cells, transfected with different tagged plasmids (as used in <xref ref-type="fig" rid="fig1">Figure 1</xref>) or a mock control plasmid, were analyzed by SDS-PAGE and western blotting. The blot was developed with NbVHH05 and Nb127D01 followed by NbALFA-HRP or a mouse anti-tubulin primary antibody followed by anti-mouse IgG HRP. (<bold>B</bold>) Schematics depict VHH05- or 127D01-tagged secreted GFP proteins bound by NbVHH05-ALFA and Nb127D01-ALFA followed by NbALFA-HRP. Culture media from S2<italic>R</italic>+ cells transfected with secreted BiP-GFP-1xtag, BiP-GFP-2xtag, BiP-GFP-3xtag were used for the western blotting. Anti-FLAG antibody was used to show the GFP level. Histogram showing the relative gray value of anti-NbVHH05 or anti-Nb127D01 to anti-FLAG. (<bold>C</bold>) Western blots for S2<italic>R</italic>+ cell culture media containing double NanoTagged Upd2 protein: N- and C-terminus region of Upd2 contain VHH05 and 127D01, respectively, recognized by NbVHH05 or Nb127D01. The secondary antibodies were anti-hIgG-HRP, anti-ALFA-800, and Streptavidin-800. (<bold>D</bold>) Immunoprecipitation of FLAG-GFP-3xVHH05 using NbVHH05-ALFA and ALFA-resin. The control nanobody failed to capture FLAG-GFP-3xVHH05. (<bold>E</bold>) Immunoprecipitation of FLAG-GFP-3x127D01 using Nb127D01-ALFA and ALFA-resin. (<bold>F</bold>) Immunoprecipitation of FLAG-GFP-3x127D01 using Nb127D01-hIgG and Protein A magnetic bead.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Raw data of Western blot for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-74326-fig3-data1-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Test of nanobody concentration gradient.</title><p>Lysates from S2<italic>R</italic>+ cells transfected with H2B-mCherry-VHH05 or H2B-mCherry-127D01 were analyzed by SDS-PAGE and western blotting. The blot was developed with NbVHH05-ALFA and Nb127D01-ALFA with a concentration gradient from 1:100, 1:1000, 1:10,000, 1:100,000, followed by NbALFA-HRP or a mouse anti-tubulin primary antibody followed by anti-mouse IgG HRP. Two conditions of long-time exposure (60 s) and short-time exposure (20 s) were set for signal reading.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Raw data of Western blot for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-74326-fig3-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Rapid production of nanobodies in S2 cells for western blots.</title><p>(<bold>A</bold>) Production workflow of nanobodies in the fly cell line. (<bold>B</bold>) Western blot using culture media containing Nb127D01-hIgG, detected by anti-hIgG-HRP. (<bold>C</bold>) Western blot using culture media containing NbVHH05-hIgG, detected by anti-hIgG-HRP. Five different concentrations and three exposure times were used.</p><p><supplementary-material id="fig3s2sdata1"><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Raw data of Western blot for <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-74326-fig3-figsupp2-data1-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig3-figsupp2-v2.tif"/></fig></fig-group><p>Next, we tested whether the nanobodies against the VHH05 and 127D01 tags could be used for multiplexed immunoblots by double-tagging the Upd2 cytokine (VHH05-Upd2-127D01). As we needed to detect each nanobody in a specific manner, we tagged one nanobody with the ALFA tag and detected it using NbALFA and the other, with an hIgG. We expressed and prepared nanobody-hIgG from S2 cells and tested different concentrations of conditioned media on immunoblots (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Very diluted conditioned media still produced a strong signal, even though the nanobody-hIgG was not purified or concentrated. After establishing working concentrations of hIgG-tagged nanobody conditioned media, we performed multiplexed immunostaining using Nb127D01-hIgG and NbVHH05-ALFA, or NbVHH05-hIgG and Nb127D01-ALFA, detected with anti-hIgG and NbALFA, respectively (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Upd2 undergoes fragmentation due to internal furin cleavage sites, which produced different bands on the immunoblot. A combination of hIgG-tagged nanobody and ALFA-tagged nanobody can thus be used for multiplexed immunoblotting (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). In addition, we confirmed that a combination of NbVHH05-biotin and Nb127D01-hIgG also worked well for multiplexed immunoblotting (<xref ref-type="fig" rid="fig3">Figure 3C</xref>).</p><p>Another key application of antibodies is immunopurification of target proteins. To explore whether NbVHH05 and Nb127D01 can be used for immunopurification, we coated NbALFA resin with ALFA-tagged NbVHH05 or Nb127D01 nanobodies and used the modified resin to recover NanoTagged FLAG-GFP secreted in S2 cell culture media. FLAG-GFP-3xVHH05 and FLAG-GFP-3x127D01 were captured by NbVHH05-ALFA and Nb127D01-ALFA, respectively (<xref ref-type="fig" rid="fig3">Figure 3D and E</xref>). Protein A magnetic beads coated with Nb127D01-hIgG also successfully recovered FLAG-GFP-3x127D01 from S2 cell culture media (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). We confirmed that the VHH05 and 127D01 systems do not cross-react (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3B</xref>). NanoTag-based immunopurification with these nanobodies is thus effective.</p></sec><sec id="s2-4"><title>NanoTag trap as a method to alter protein localization</title><p>One of the many possible applications of nanobodies is to express them in cells or in vivo as fusion proteins localized to a particular subcellular location, in order to manipulate the localization of a NanoTagged POI. To test whether the NbVHH05/VHH05-tag and Nb127D01/127D01-tag can be used to alter localization, we constructed secreted GFP expression vectors that - had an N-terminal BiP signal peptide and a C-terminal VHH05- or 127D01-tag (BiP-GFP-VHH05 and BiP-GFP-127D01) (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>). We also constructed NbVHH05 and Nb127D01 with mCherry and KDEL endoplasmic reticulum (ER) retention signal (BiP-Nanobody-mCherry-KDEL), which should result in retention of the fusion protein in the ER (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>). When transfecting only BiP-GFP-VHH05 or BiP-GFP-127D01 into S2<italic>R</italic>+ cells, we did not observe GFP accumulation within cells, as the GFP proteins were actively secreted into the culture medium (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). However, after co-transfecting BiP-NbVHH05-mCherry-KDEL with BiP-GFP-VHH05, or BiP-Nb127D01-mCherry-KDEL with BiP-GFP-127D01, we observed intracellular accumulation of GFP that co-localized with the mCherry signal. This shows that NanoTagged-GFP proteins directed to the secretory pathway can be trapped by an ER NanoTag trap (i.e. nanobodies with an ER retention signal) (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Indeed, cell lysates prepared from cells transfected with ER NanoTag trap showed more GFP signal on immunoblot, compared to controls lacking the ER NanoTag trap (<xref ref-type="fig" rid="fig4">Figure 4D</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Nanobody-based system for altering localization of NanoTagged proteins.</title><p>(<bold>A and B</bold>) Diagram showing the vectors used for the secreted protein trapping method. NbVHH05/Nb127D01 fused to mCherry contain KDEL and BiP signal peptide and is driven by the actin5C promoter. (<bold>C</bold>) Four independent cell transfection experiments were performed. In 1 and 3, only GFP-VHH05 or GFP-127D01 was transfected. In 2 and 4, NbVHH05-mCherry-KDEL with GFP-VHH05, or Nb127D01-mCherry-KDEL with GFP-127D01, were co-transfected. Images show the GFP and mCherry signal 48 hr after transfection. Nuclei are stained with 4′,6-diamidino-2-phenylindole (DAPI). (<bold>D</bold>) Immunoblots of GFP and tubulin in cell lysates from transfections 1–4.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Raw data of Western blot for <xref ref-type="fig" rid="fig4">Figure 4D</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-74326-fig4-data1-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Nanobody-based system for altering localization of NanoTagged proteins.</title><p>(<bold>A and B</bold>) Diagram showing the vectors used for cytoplasmic protein trapping. NbVHH05/Nb127D01 is fused to GFP and CD8, and driven by actin5C promoter. Target proteins are mCherry containing VHH05-tag or 127D01-tag at the C-terminus and mito signal at the N-terminus. (<bold>C</bold>) Results of transfection of mito-mCherry-NanoTag or co-transfection of CD8-NbVHH05-GFP/mito-mCherry-VHH05 and CD8-Nb127D01-GFP/mito-mCherry-127D01 in S2<italic>R</italic>+ cells. GFP, mCherry, and merged channels show protein expression levels with antibody staining.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig4-figsupp1-v2.tif"/></fig></fig-group><p>We also prepared membrane-tethered nanobodies (membrane NanoTag trap) in order to re-localize cytoplasmic NanoTagged proteins to the membrane (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A, B</xref>). When S2<italic>R</italic>+ cells were co-transfected with CD8-NbVHH05-GFP/mito-mCherry-VHH05 or CD8-Nb127D01-GFP/mito-mCherry-127D01, mCherry co-localized with GFP on the cell membrane (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). NanoTag traps targeted to particular cellular compartments can thus alter the subcellular distribution of NanoTagged proteins. The ability to do so may facilitate a variety of functional analyses.</p></sec><sec id="s2-5"><title>Assessing NanoTags in vivo</title><p>The successful use of the NbVHH05/VHH05-tag and Nb127D01/127D01-tag in cells prompted us to test them in vivo. We first constructed a series of UAS vectors with either a cytoplasmic or secreted version of the two nanobodies, tagged with GFP or HA (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>), and tested them in cells. As expected, when transfected together with the <italic>pAct-Gal4</italic> plasmid, the cytoplasmic expression vectors led to an expression of nanobodies detectable in S2<italic>R</italic>+ cell lysates, and the secretory expression vectors resulted in detection of nanobodies predominantly in the culture media (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B, C</xref>). Next, we generated transgenic flies carrying these UAS constructs. We did not expect NbVHH05 or Nb127D01 to interact with any fly endogenous proteins for lack of obvious sequence similarity between the <italic>Drosophila</italic> proteome and the amino acid sequence of the two tags (data not shown). To confirm this experimentally, we ubiquitously expressed NbVHH05 or Nb127D01 in vivo throughout development using <italic>tubulin-Gal4</italic>. The nanobodies were not toxic to flies; we readily obtained adult <italic>tubulin-Gal4</italic>, <italic>UAS-Nanobody</italic> flies and did not observe any detectable developmental defects or abnormalities (data not shown). To further test these constructs, we used fat body-specific <italic>Lpp-Gal4</italic> to drive NbVHH05 or Nb127D01 expression. Immunofluorescence showed that GFP- or HA-tagged NbVHH05 or Nb127D01 is expressed at readily detectable levels in fat body cells (<xref ref-type="fig" rid="fig5">Figure 5A–D</xref>). We also confirmed that nanobodies with the BiP signal peptide are secreted (<xref ref-type="fig" rid="fig5">Figure 5E and F</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Nanobodies expression in vivo.</title><p>(<bold>A–D</bold>) <italic>Lpp-Gal4</italic> drives fat body expression of <italic>UAS-NbVHH05-GFP</italic>, <italic>UAS-NbVHH05-HA, UAS-Nb127D01-GFP,</italic> or <italic>UAS-Nb127D01-HA</italic>, detected by GFP or anti-HA immunostaining. (<bold>E and F</bold>) Western blot detection of cytoplasmic and secreted GFP- or HA-tagged nanobodies. Lysates from fat body or hemolymph were tested by anti-GFP, anti-HA, and anti-tubulin antibodies. Cytoplasmic-expressed nanobodies: <italic>UAS-NbVHH05-GFP, UAS-Nb127D01-GFP, UAS-NbVHH05-HA,</italic> and <italic>UAS-Nb127D01-HA</italic>. Secreted-expressed nanobodies: <italic>UAS-BiP-NbVHH05-GFP, UAS-BiP-Nb127D01-GFP, UAS-BiP-NbVHH05-HA,</italic> and <italic>UAS-BiP-Nb127D01-HA</italic>. (<bold>G–J</bold>) Confocal images of <italic>Drosophila</italic> adult guts expressing 127D01-EGFP/VHH05-GFP and VHH05-REPTOR-127D01 with or without rapamycin (Rapa) treatment for 15 hr. REPTOR shuttles into the nucleus upon Rapa treatment. (<bold>G</bold> and <bold>I</bold>) as controls only express 127D01-EGFP or VHH05-GFP in the ECs. (<bold>H</bold>) combines 127D01-EGFP with VHH05-REPTOR-127D01 and (<bold>J</bold>) combines VHH05-EGFP with VHH05-REPTOR-127D01.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Raw data of Western blot for <xref ref-type="fig" rid="fig5">Figure 5E and F</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-74326-fig5-data1-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Transgenic vector information and test in S2<italic>R</italic>+ cells.</title><p>(<bold>A</bold>) Series of UAS vectors expressing NbVHH05 and Nb127D01 fused to GFP and HA or containing BiP signal. Transcriptional elements such as the promoter and SV40 of the expression vectors, and the different protein coding modules are represented as colored filled boxes. (<bold>B</bold>) Lysates or culture media from S2<italic>R</italic>+ cells transfected with GFP vectors were analyzed by SDS-PAGE and by western blot. The blot was developed with anti-GFP antibody or anti-tubulin antibody. (<bold>C</bold>) Lysates or culture media from S2<italic>R</italic>+ cells transfected with HA vectors were analyzed by SDS-PAGE and by western blot. The blot was developed with anti-HA antibody or anti-tubulin antibody. (<bold>D</bold>) Two types of UAS vectors for overexpressing NanoTag-labeled genes. N-, C-terminal of protein of interest (POI) contains VHH05 and 127D01. BiP is the signal for labeling secreted proteins. (<bold>E</bold>) Five secreted proteins and three cytoplasm proteins were labeled, and their sizes are indicated. (<bold>F</bold>) Western blot results of three small size secreted proteins, Akh and Dilp8 showed multiple bands, and Dilp2 only showed a single band. (<bold>G</bold>) Western blot results of Pvf1, Upd2, REPTOR-bp-B, REPTOR-bp-C, REPTOR-bp-B. The blot was developed with NbVHH05-ALFA and Nb127D01-ALFA followed by NbALFA-HRP in F and G.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Raw data of Western blot for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-74326-fig5-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Immunostaining of double NanoTag-labeled proteins.</title><p>(<bold>A and B</bold>) are control Oregon-R flies stained with NbVHH05 and Nb127D01. (<bold>C and D</bold>) <italic>UAS-VHH05-REPTOR-bp-C-127D01</italic> driven by <italic>Myo1A<sup>ts</sup>-Gal4</italic> adult fly guts stained with NbVHH05 and Nb127D01. (<bold>E and F</bold>) <italic>UAS-BiP-VHH05-Upd2-127D01</italic> driven by <italic>Myo1A<sup>ts</sup>-Gal4</italic> adult fly guts stained with NbVHH05 and Nb127D01. Red box indicates an enlarged area of the gut.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig5-figsupp2-v2.tif"/></fig></fig-group><p>To address whether NanoTagged POIs can be detected in vivo, we generated <italic>UAS-VHH05-REPTOR-127D01</italic> flies. A previous study has shown that in S2 cells, the transcription factor REPTOR is enriched in the cytoplasm under normal conditions but translocates into the nucleus upon rapamycin treatment (<xref ref-type="bibr" rid="bib30">Tiebe et al., 2015</xref>). To test whether the changes in REPTOR localization can be detected using the nanobodies, we co-expressed NanoTagged REPTOR along with Nb127D01-GFP or NbVHH05-GFP specifically in adult enterocytes (ECs). In the absence of a NanoTagged POI, Nb127D01-GFP and NbVHH05-GFP were detected in both the cytoplasm and nuclei (<xref ref-type="fig" rid="fig5">Figure 5G1</xref>). In contrast, when co-expressed with NanoTagged REPTOR, the nanobody-GFP signals were enriched in the cytoplasm of ECs under normal food conditions (<xref ref-type="fig" rid="fig5">Figure 5H and J</xref>). Following rapamycin treatment, a stronger GFP signal was observed in nuclei. Similar changes were absent from ECs that express Nb127D01-GFP or NbVHH05-GFP alone (<xref ref-type="fig" rid="fig5">Figure 5G1</xref>). These results confirm that rapamycin treatment leads to translocation of REPTOR into the nucleus in vivo and provide further support for the idea that co-expression of NanoTagged POIs and nanobodies can visualize the subcellular location of a POI (<xref ref-type="fig" rid="fig5">Figure 5H and J</xref>).</p><p>Next, we checked whether NanoTagged proteins can be detected in vitro and in vivo using purified nanobodies. We first constructed several vectors that contain NanoTags at the N- or C-terminus of POIs and tested them in S2<italic>R</italic>+ cells. For secreted proteins, we replaced the endogenous signal peptide with the BiP signal peptide (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). NanoTagged Akh, Dilp2, Dilp8, Pvf1, and Upd2 were readily detected in the culture media using NbVHH05 or Nb127D01 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>). REPTOR and two isoforms of REPTOR-BP (REPTOR-BP-B and REPTOR-BP-C) could also be detected using NbVHH05 or Nb127D01 from transfected S2<italic>R</italic>+ cell lysates (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F, G</xref>). In addition to <italic>VHH05-REPTOR-127D01</italic> flies, we also generated two additional transgenic flies: <italic>UAS-VHH05-REPTOR-BP-C-127D01</italic> and <italic>UAS-BiP-VHH05-Upd2-127D01</italic> (a version of Upd2 with the BiP secretion signal and both NanoTags). We used <italic>Myo1A</italic><sup>ts</sup> to drive <italic>UAS-VHH05-REPTOR-BP-C-127D01</italic> and <italic>UAS-BiP-VHH05-Upd2-127D01</italic> and were able to detect the signal in adult midguts, using either NbVHH05 or Nb127D01 for detection by immunofluorescence (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Taken together, these data indicate that both NbVHH05/VHH05-tag and Nb127D01/127D01-tag work well for in vivo imaging and immunostaining.</p></sec><sec id="s2-6"><title>CRISPR-mediated tagging of endogenous genes with NanoTags</title><p>In many cases, tagging endogenous proteins is preferable to UAS-based overexpression of tagged cDNAs, as UAS/Gal4-mediated expression can exceed physiological levels. Further, while many proteins have been tagged endogenously with GFP (<xref ref-type="bibr" rid="bib25">Morin et al., 2001</xref>; <xref ref-type="bibr" rid="bib28">Sarov et al., 2016</xref>; <xref ref-type="bibr" rid="bib20">Li-Kroeger et al., 2018</xref>), tagging with smaller epitope tags may be preferable to minimize their structural impact. To tag endogenous genes with either VHH05-tag or 127D01-tag, we used a standard CRISPR-Cas9 targeted insertion method to tag fly proteins at their N- or C- terminus via the homology directed repair pathway (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A, B, C</xref>). To facilitate this approach, we first designed four universal vectors based on the scarless editing CRISPR knock-in (KI) approach (<xref ref-type="bibr" rid="bib19">Lamb et al., 2017</xref>). Each vector contains five common features: the encoded NanoTags for N- or C-terminal tagging, <italic>3xP3-dsRed-SV40</italic> for identification of transformants, 5’/3’ terminal repeats for piggyBac transposase recognition sequences, TTAA for piggyBac target sequence, and an EcoRI restriction site for cloning target locus homologous arms by Gibson assembly (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A’</xref>). We chose histone H2A variant (H2Av) as an example, because the expected nuclear localization of H2Av should be easily visualized. We cloned the sequence 1 kb upstream and 1 kb downstream of the stop codon (TAA) into the donor vector (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A</xref>). A- sgRNA plasmid that targeted a seed sequence near the TAA of H2Av gene was injected into <italic>yw; nos-cas9/CyO</italic> embryos together with the donor plasmid (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B’</xref>). Positive transformants with red fluorescent eyes were outcrossed and successful KI events were confirmed by junction PCR and sequencing (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C’</xref>). Subsequently, 3xP3dsRed was excised using piggyBac transposase (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2B</xref>). After sequence verification (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C</xref>), we immunostained midguts from H2Av-3x127D01 and H2Av-3xVHH05-expressing flies using Nb127D01-HA/NbVHH05-HA or NbVHH05-555/NbVHH05-biotin. As shown in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D’</xref> and <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2D</xref>, H2Av tagged with either NanoTag was clearly observed in the nucleus, demonstrating that this tagging method can be used effectively to engineer NanoTagged forms of POIs and study their localization and/or function at physiological expression levels.</p><p>In order to further test the sensitivity and the possibility of labeling secreted small peptides by the KI method, we selected <italic>Dilp2</italic> as an example. The above results showed that the double NanoTagged Dilp2 can be secreted into S2<italic>R</italic>+ culture medium and detected by western blot using NbVHH05 or Nb127D01 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F</xref>). Here, we integrated 3x127D01 into the C-terminal of endogenous <italic>Dilp2</italic> using KI strategy (<xref ref-type="fig" rid="fig6">Figure 6A, B, C</xref>). After confirming the proper integration (<xref ref-type="fig" rid="fig6">Figure 6D</xref>), we compared Nb127D01 and Dilp2 antibody stainings in the larval brain, which revealed similar expression patterns (<xref ref-type="fig" rid="fig6">Figure 6E</xref>; <xref ref-type="bibr" rid="bib27">Park et al., 2014</xref>). Since introducing tags to proteins can negatively affect their functions and a previous study has shown that <italic>Dilp2</italic> RNAi increases trehalose levels (<xref ref-type="bibr" rid="bib6">Broughton et al., 2008</xref>), we examined the trehalose level of 127D01-tagged Dilp2 expressing flies. No difference was observed compared to control (<xref ref-type="fig" rid="fig6">Figure 6G</xref>), suggesting that that NanoTagged Dilp2 is functional. Furthermore, the change in Dilp2 signal in IPC cells and their neuronal projections in larval brain after starvation was easily detected by Nb127D01 immunostaining (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). These results indicate that the CRISPR-mediated tagging of endogenous genes with NanoTags can be used for detecting small peptides with high sensitivity.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Integration of <italic>3x127D01</italic> into <italic>Dilp2</italic> shows a robust expression pattern in the brain.</title><p>(<bold>A</bold>) Workflow and schematic representation of the <italic>Dilp2</italic> gene and the sgRNA targeting site. (<bold>B</bold>) PCR amplification was used to confirm the insertion. (<bold>C</bold>) Representative sequencing chromatogram of PCR products from the junction PCR. (<bold>D</bold>) Sequencing results of the DNA fragments showing 3x127D01-tag genome–donor integration. (<bold>E</bold>) Larval brains of <italic>w1118</italic> and <italic>Dilp2−3x127D01</italic> co-stained with anti-Dilp2 antibody and Nb127D01. Box demarcates Dilp2-expressing cells and Dilp2-positive neuronal projections. (<bold>F</bold>) Measurement of whole body trehalose concentration in <italic>y,w</italic> and <italic>y,w; Dilp2−3x127D01</italic> flies. Data are represented as mean ± SD and two-tailed t-tests were used to generate p values, n.s. indicates statistically non-significant. (<bold>G</bold>) Nanobody immunostaining showing different Dilp2 expression after starvation. Red outline demarcates Dilp2-expressing cells and white outline demarcates Dilp2-positive neuronal projections. Scale bars: 100 µm.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Raw data of agarose gel electrophoresis diagram for <xref ref-type="fig" rid="fig6">Figure 6B</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-74326-fig6-data1-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Endogenous VHH05- or 127D01-tagging using CRISPR/Cas9.</title><p>Workflow (<bold>A</bold>), fly embryos transformation (<bold>B</bold>), genotyping (<bold>C</bold>), and applications (<bold>D</bold>). (<bold>A’</bold>) Common scarless vectors used for constructing donors. N-terminal vectors (PHD-N-3x127D01-donor or PHD-N-3xVHH05-donor) and C-terminal vectors (PHD-C-3x127D01-donor or PHD-C-3xVHH05-donor) contain EcoRI restriction enzyme sites that introduce the homologous arm sequences into donors. (<bold>B’</bold>) Workflow example for introducing knock-in (KI) tags into the third chromosome. (<bold>C’</bold>) Genotyping example of KI 3xVHH05-tag and 3x127D01-tag into the C-terminus of H2A variant (H2Av). Gel results showing the 5’ and 3’ PCR junctions. Representative sequencing chromatogram of PCR products from the junction PCR. (<bold>D’</bold>) Immunostaining of H2Av-3x127D01 and H2Av-3xVHH05. Adult male or female guts were dissected and stained with Nb127D01-HA or NbVHH05-HA. Scale bars: 20 µm.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Raw data of agarose gel electrophoresis diagram for <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-74326-fig6-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig6-figsupp1-v2.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Schematic representation of the CRISPR/Cas9-mediated gene knock-in approach and the targeted integration of transgene constructs.</title><p>(<bold>A</bold>) Schematic representation of the H2A variant (<italic>H2Av</italic>) gene and the sgRNA targeting site. The thin gray line represents the <italic>H2Av</italic> genomic locus, with open boxes indicating the promoter, exons, and poly(A) signal. A 164 bp fragment (gray box) located at the 5′ end represents the 5' UTR. The two 79, 119, and 233 bp fragments (pink boxes) are exon 1, exon 2, and exon 3, respectively. A 322 bp fragment (gray box) located at the 3′ end is the poly(A) signal. The red lightning icon indicates the sgRNA site. In the PHD donor construct, the DsRed2 marker expression cassette is driven by the eye-specific 3xP3 promoter. DNA fragments of 999 and 999 bp at the 5′ and 3′ ends were PCR-amplified, subcloned into vectors, and used as homology arms (5' HR and 3' HR, respectively). The 3xNanoTag sequence is shown in the green box. 3’ terminal repeat and 5’ terminal repeats are the piggyBac transposase recognition sequences. Primer positions for amplification analysis of the integrated insertions in transformed flies are shown by arrows. Primer pairs of F1/R1 and F2/R2 were used to amplify the 5′- and 3′-end insertion junctions, respectively. The donor plasmid and sgRNA were injected into the embryos and the donors integrated into the genome. Positive individuals were screened for red fluorescence of the eye. The selection marker was removed by crossing with flies expressing the transposase. Primer pairs of F3/R3 were used to amplify the final insertion. (<bold>B</bold>) PCR amplification was used to confirm the insertions. Two <italic>H2Av-3x127D01</italic>, four <italic>H2Av-3xVHH05</italic> heterozygous, and <italic>w1118</italic> genomic DNA were used as template and the thick gel bands showed the corrected insertion. (<bold>C</bold>) Sequencing results of the integrated diagnostic DNA fragments showing 3xtag genome–donor integration. (<bold>D and E</bold>) Indirect immunostaining of <italic>H2Av-3xVHH05</italic> flies. Adult female guts were dissected and stained with NbVHH05-biotin and visualized by Streptavidin-488. (<bold>F and G</bold>) Direct immunostaining of <italic>H2Av-3xVHH05</italic> flies. Adult female guts were dissected and stained with NbVHH05-555. (A and C) were <italic>w1118</italic>, (B and D) are <italic>H2Av-3xVHH05</italic>. Scale bars: 20 µm.</p><p><supplementary-material id="fig6s2sdata1"><label>Figure 6—figure supplement 2—source data 1.</label><caption><title>Raw data of agarose gel electrophoresis diagram for <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2B</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-74326-fig6-figsupp2-data1-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-74326-fig6-figsupp2-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we characterized two NanoTags (VHH05 and 127D01) and their corresponding nanobodies (NbVHH05 and Nb127D01), for use in <italic>Drosophila</italic> for cellular and in vivo studies. We show that these two systems can be used for in vivo detection via chromobodies (CBs), re-localization, direct or indirect immunostaining, immunoblotting, and immunopurification. The observation that these nanobodies recognize the NanoTags on immunoblots is particularly useful, as only few nanobodies that recognize a defined amino acid sequence have been characterized as suitable for immunoblotting (<xref ref-type="bibr" rid="bib10">Cheloha et al., 2020</xref>) The utility of this system is further enhanced by ease of purification of nanobodies from either bacterial cells or <italic>Drosophila</italic> cultured cells. Modification of these nanobodies with ALFA or HA tags facilitates detection. Installation of a human Fc portion on these nanobodies enables the use of anti-human IgG antibodies as secondary reagents for detection. In addition, we used chemical labeling or site-specific sortase labeling to prepare nanobodies labeled with fluorophores or biotin. We have thus developed reagents with broad applicability in <italic>Drosophila</italic> research and beyond.</p><p>The system described here has significant advantages over conventional antibodies or anti-GFP nanobodies. Nanobodies, unlike conventional antibodies, are easily encoded as a single open reading frame in the genomes of model organisms or cells. In addition, the small size of the NanoTags may be preferable in many cases to GFP, as GFP is bulky and may affect the function of the tagged protein. Also, the relatively long protein maturation time of GFP limit its use for imaging nascent proteins. Finally, the anti-GFP nanobody, as used in deGradFP (<xref ref-type="bibr" rid="bib7">Caussinus et al., 2011</xref>), only poorly recognizes unfolded GFP.</p><p>We show how these short tags can be introduced into endogenous genes, using the scarless CRISPR KI editing approach. Given the small size of the tags, additional methods for genome modification deserve to be explored. For example, ssDNA-based CRISPR KI can be used to insert short sequences into a precise location in the genome (<xref ref-type="bibr" rid="bib21">Ling et al., 2017</xref>). Another possibility is prime editing, which relies on pegRNAs to insert sequences smaller than 48 bp into a chosen genomic position (<xref ref-type="bibr" rid="bib2">Anzalone et al., 2019</xref>; <xref ref-type="bibr" rid="bib4">Bosch et al., 2021</xref>).</p><p>A key feature of the NanoTag/nanobody system is the ability to co-express the nanobody in vivo in the form of a CB or some other fusion. We show that this approach can be used to re-localize proteins. Expression in vivo also opens the doors to using versions of the deGrad system or other functional fusions to manipulate proteins in other ways (<xref ref-type="bibr" rid="bib8">Caussinus and Affolter, 2016</xref>). Some S2<italic>R</italic>+ cells transfected with Nb127D01-GFP contained aggregates (data not shown). However, we did not observe aggregates in Nb127D01-mCherry transfected cells or transgenic Nb127D01-GFP flies, nor did we observe developmental defects or negative effects on viability following expression of the tags and/or nanobodies in vivo. The occasional observation of protein aggregation in cells more likely reflects the high level of expression when transfecting cells with exogenous expression constructs.</p><p>Given their versatility and in vivo applications, we anticipate that the two NanoTags and corresponding nanobodies will be useful to address many cell biological questions. The relative ease with which the system can be used for in vivo tagging as well as our demonstration that the system can be used in a number of ways for imaging (i.e. using CBs or direct or indirect immunofluorescence) are obvious assets. The NanoTag approach might be particularly useful for the new and growing need to spatially map cell clusters identified from scRNAseq studies (<xref ref-type="bibr" rid="bib24">Mohr et al., 2021</xref>). Other potential applications for in vivo tagged proteins include chromosome immunoprecipitation, immunopurification of protein complexes, and inducing degradation of proteins that carry the tag (e.g. as shown for GFP in <xref ref-type="bibr" rid="bib7">Caussinus et al., 2011</xref>; <xref ref-type="bibr" rid="bib26">Neumüller et al., 2012</xref>). Another benefit of double labeling is that nanobody binding (for manipulation) may prohibit subsequent detection of the protein by the same nanobody; for example, when membrane localized Nanobody 1 is used to manipulate the localization of Protein X-NanoTag 1, Nanobody 1 cannot be used to visualize Protein X-NanoTag 1. This issue can be resolved with double NanoTagged proteins (NanoTag2-proteinX-NanoTag1), as Nanobody 2-Fluorophore should allow detection when membrane-localized Nanobody 1 is used as a trap.</p><p>Although we developed and validated the NanoTag system for use in <italic>Drosophila</italic>, the same approaches should be applicable to other systems. The mouse genome contains a predicted amino acid sequence with 100% identity to the epitope recognized by VHH05, which is not surprising, given that the tag sequence is identical to a segment of the human source protein, Ube6e. For 127D01, however, no proteins encoded by the mouse genome have peptides with more than 50% identity to the tag, suggesting that 127D01 could be used for murine studies. Moreover, there are no peptides with more than 50% identity to either tag in many species of research interest, including <italic>E. coli, Saccharomyces cerevisiae, C. elegans, Arabidopsis thaliana, Oryza sativa</italic> (rice), the mosquitoes <italic>Aedes aegypti, Anopheles gambiae</italic> and <italic>Anopheles stephensi, Bombyx mori</italic> (silkworm), <italic>Tribolium castaneum</italic> (red flour beetle), <italic>Danaus plexippus</italic> (monarch butterfly), and <italic>D. rerio</italic> (zebrafish), suggesting that both tags could be used in these organisms.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Mouse monoclonal anti-a-Tubulin</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# T5168; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_477579">AB_477579</ext-link></td><td align="left" valign="top">WB (1:10,000)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Mouse monoclonal anti-GFP</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">Cat# A11120; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_221568">AB_221568</ext-link></td><td align="left" valign="top">IF (1:300)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Rabbit polyclonal anti-GFP</td><td align="left" valign="top">Molecular Probes</td><td align="left" valign="top">Cat# A-6455 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_221570">AB_221570</ext-link></td><td align="left" valign="top">WB (1:10,000)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Rat monoclonal anti-HA</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# 3 F10; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2314622">AB_2314622</ext-link></td><td align="left" valign="top">WB (1:10,000) IF (1:1000)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Mouse monoclonal anti-FLAG M1</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# F3040; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_439712">AB_439712</ext-link></td><td align="left" valign="top">WB (1:5000)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Rabbit polyclonal anti-Dilp2</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib27">Park et al., 2014</xref></td><td align="left" valign="top">N/A</td><td align="left" valign="top">IF (0.5 µg/ml)</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">NbALFA-HRP</td><td align="left" valign="top">NanoTag Biotechnologies</td><td align="left" valign="top">Cat# N1502-HRP</td><td align="left" valign="top">WB (1:5000)</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">NbALFA-Atto647</td><td align="left" valign="top">NanoTag Biotechnologies</td><td align="left" valign="top">Cat# N1502-At647N-L</td><td align="left" valign="top">IF (1:500)</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">NbALFA-800CW</td><td align="left" valign="top">NanoTag Biotechnologies</td><td align="left" valign="top">Cat# N1502-Li800-L</td><td align="left" valign="top">WB (1:5000)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Goat anti-alpaca IgG-647</td><td align="left" valign="top">Jackson ImmunoResearch</td><td align="left" valign="top">Cat# 128-605-230 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2810930">AB_2810930</ext-link></td><td align="left" valign="top">IF (1:500)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Mouse monoclonal anti-HA-Alexa Fluor 488</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# A-21287 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535829">AB_2535829</ext-link></td><td align="left" valign="top">IF (1:1000)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Goat anti-human IgG Fc-HRP</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# A18829 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535606">AB_2535606</ext-link></td><td align="left" valign="top">WB (1:5000)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Donkey anti-human IgG-DyLight 680</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# SA5-10130 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2556710">AB_2556710</ext-link></td><td align="left" valign="top">WB (1:5000)</td></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">Streptavidin-DyLight 800</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# 21851</td><td align="left" valign="top">WB (1:5000)</td></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">Streptavidin-Alexa Fluor 488</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# S32354 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2315383">AB_2315383</ext-link></td><td align="left" valign="top">IF (1:500)</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">NbVHH05-HA</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">WB (1:5000) IF (1:500) See *Note</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">NbVHH05-ALFA</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">WB (1:5000) IF (1:500) See *Note</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">NbVHH05-hIgG</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">WB (1:100) IF (1:20) See *Note</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">NbVHH05-555</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">IF (1:500) See *Note</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">NbVHH05-biotin (sortagging)</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">IF (1:500) See *Note</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">NbVHH05 –555 (sortagging)</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">IF (1:500) See *Note</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Nb127D01-HA</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">WB (1:5000) IF (1:500) See *Note</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Nb127D01-ALFA</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">WB (1:5000) IF (1:500) See *Note</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Nb127D01-hIgG</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">WB (1:100) IF (1:20) See *Note</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Nb127D01-647</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">IF (1:500) See *Note</td></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">Phusion polymerase</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# M0530</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">Q5 polymerase</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# M0494</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">Taq polymerase</td><td align="left" valign="top">Clontech</td><td align="left" valign="top">Cat# TAKR001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">EcoRI</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# R0101</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">XbaI</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# R0145</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">BglII</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# R0144</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">NheI</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# R3131</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">NsiI-HF</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# R3127</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">NcoI-HF</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# R3193</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">XhoI</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# R0146</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">BbsI</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# R0539</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">AarI</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# ER1581</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">T4PNK</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# M0201</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">T4 DNA ligase</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# M0202</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">Fetal bovine serum</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# A3912</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Schneider’s media</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# 21720–024</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Penicillin-streptomycin</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# 15070–063</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">ESF921 media</td><td align="left" valign="top">Expression Systems</td><td align="left" valign="top">Cat# 96–001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">Proteinase K</td><td align="left" valign="top">Roche</td><td align="left" valign="top">Cat# 3115879001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">RNase A</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# EN0531</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">Protease and phosphatase inhibitor cocktail</td><td align="left" valign="top">Pierce</td><td align="left" valign="top">Cat# 78440</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Trypsin inhibitor benzamidine</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# 434760</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Rapamycin</td><td align="left" valign="top">LC Laboratories</td><td align="left" valign="top">Cat# R-5000</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">HRP-Conjugated Streptavidin</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# N100</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">Trehalase (prokaryote)</td><td align="left" valign="top">Megazyme</td><td align="left" valign="top">Cat# E-TREH</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Gibson assembly</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# E2611</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">NEBuilder HiFi assembly</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# E2621</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Golden Gate Assembly</td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# E1601</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">pJET-1.2 vector kit</td><td align="left" valign="top">Fermentas</td><td align="left" valign="top">Cat# K1231</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">QIAquick Gel Extraction Kit</td><td align="left" valign="top">Qiagen</td><td align="left" valign="top">Cat# 28706</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">QIAquick Spin Columns</td><td align="left" valign="top">Qiagen</td><td align="left" valign="top">Cat# 28115</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Effectene</td><td align="left" valign="top">Qiagen</td><td align="left" valign="top">Cat# 301427</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">B-PER II Bacterial Protein Extraction Reagent</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# 78260</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Mix-n-Stain CF 555 Antibody Labeling Kit</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# MX555S100 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10960067">AB_10960067</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Mix-n-Stain CF 647 Antibody Labeling Kit</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# MX647S100 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10961766">AB_10961766</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Ni-NTA resin</td><td align="left" valign="top">EMD Millipore</td><td align="left" valign="top">Cat# 70691–3</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">PD-10 column</td><td align="left" valign="top">GE Healthcare</td><td align="left" valign="top">Cat# GE17-0851-01</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Lysis buffer</td><td align="left" valign="top">Pierce</td><td align="left" valign="top">Cat# 87788</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">SDS sample buffer</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# 39001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">4–20% polyacrylamide gel</td><td align="left" valign="top">Bio-Rad</td><td align="left" valign="top">Cat# 4561096</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Enhanced chemiluminescence (ECL) reagents</td><td align="left" valign="top">Amersham</td><td align="left" valign="top">Cat# RPN2209</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Enhanced chemiluminescence (ECL) reagents</td><td align="left" valign="top">Pierce</td><td align="left" valign="top">Cat# 34095</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">ALFA Selector ST resin</td><td align="left" valign="top">Nanotag Biotechnologies</td><td align="left" valign="top">Cat# N1511</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Pierce IP lysis buffer</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# 87787</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Protein A magnetic beads</td><td align="left" valign="top">Bio-Rad</td><td align="left" valign="top">Cat# 1614013</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Tetramethylbenzidine-containing solution</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# N301</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Glucose Hexokinase Reagents</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# TR15421</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW</td><td align="left" valign="top">Perrimon lab</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pWalium10</td><td align="left" valign="top">DGRC</td><td align="left" valign="top">Cat# 1470</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pMK-33GW</td><td align="left" valign="top">Perrimon lab</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pET-26b</td><td align="left" valign="top">Novagen</td><td align="left" valign="top">Cat# 69862</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pQUASp-mCD8mCherry</td><td align="left" valign="top">Addgene</td><td align="left" valign="top">Cat# 46164 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_46164">Addgene_46164</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pBac (3xP3-gTc’v; pUb:lox-mYFP-lox-H2BmCherry)</td><td align="left" valign="top">Addgene</td><td align="left" valign="top">Cat# 119064 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_119064">Addgene_119064</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pcDNA4TO-mito-mCherry-10xGCN4_v4</td><td align="left" valign="top">Addgene</td><td align="left" valign="top">Cat# 60914 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_60914">Addgene_60914</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">PXL-IE1-EGFP-nos-Cas9</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib35">Xu et al., 2020</xref></td><td align="left" valign="top">N/A</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pScarlessHD-2xHA-DsRed</td><td align="left" valign="top">Addgene</td><td align="left" valign="top">Cat# 80822 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_80822">Addgene_80822</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pCFD3</td><td align="left" valign="top">Addgene</td><td align="left" valign="top">Cat# 49410 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_49410">Addgene_49410</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-NbVHH05-GFP</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171570</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-Nb127D01-GFP</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171571</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-NbVHH05-mCherry</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171572</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-Nb127D01-mCherry</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171573</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-H2B-mCherry-VHH05</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-mito-mCherry-VHH05</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-CD8-mCherry-VHH05</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-H2B-mCherry-127D01</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-mito-mCherry-127D01</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-CD8-mCherry-127D01</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-VHH05-H2B-mCherry</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-CD8-VHH05-mCherry</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-127D01-H2B-mCherry</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-CD8-127D01-mCherry</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-BiP-NbVHH05-mCherry-KDEL</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171574</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-BiP-Nb127D01-mCherry-KDEL</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171575</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-CD8-NbVHH05-GFP</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171576</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-CD8-Nb127D01-GFP</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171577</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-HGP-BiP-FLAG-GFP-VHH05</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-HGP-BiP-FLAG-GFP-2xVHH05</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-HGP-BiP-FLAG-GFP-3xVHH05</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-HGP-BiP-FLAG-GFP-127D01</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-HGP-BiP-FLAG-GFP-2x127D01</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pAW-HGP-BiP-FLAG-GFP-3x127D01</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-BiP-127D01-Akh-VHH05</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-BiP-127D01-Dilp2-VHH05</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-BiP-127D01-Dilp8-VHH05</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-BiP-127D01-Pvf1-VHH05</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-127D01-REPTOR-bp-B-VHH05</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-127D01-REPTOR-bp-C-VHH05</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pMT-HGP-v3-Nb127D01-hIgG</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171564</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pMT-HGP-v3-NbVHH05-hIgG</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171565</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pET-26b-Nb127D01-HA-His</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171566</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pET-26b-NbVHH05-HA-His</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171567</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pET-26b-Nb127D01-ALFA-His</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171568</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pET-26b-NbVHH05-ALFA-His</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171569</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-NbVHH05-HA</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-BiP-NbVHH05-HA</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-Nb127D01-HA</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-BiP-Nb127D01-HA</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-NbVHH05-GFP</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-BiP-NbVHH05-GFP</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-Nb127D01-GFP</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-BiP-Nb127D01-GFP</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-127D01-REPTOR-VHH05</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-BiP-127D01-Upd2-VHH05</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pW10-UAS-BiP-127D01-Akh-VHH05</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pCFD3-H2Av-sgRNA</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pScarlessHD-C-3x127D01-H2Av-DsRed</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pScarlessHD-C-3xVHH05-H2Av-DsRed</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pScarlessHD-C-3x127D01-DsRed</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171578</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pScarlessHD-C-3xVHH05-DsRed</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171580</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pScarlessHD-N-3x127D01-DsRed</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171579</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pScarlessHD-N-3xVHH05-DsRed</td><td align="left" valign="top">This paper Addgene</td><td align="left" valign="bottom">Cat# 171581</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Cell line (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">S2R+</td><td align="left" valign="top">DGRC</td><td align="left" valign="top">Cat# 150 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_Z831">CVCL_Z831</ext-link></td><td align="left" valign="top">FlyBase Report: FBtc0000150</td></tr><tr><td align="left" valign="top">Cell line (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">ESF921-adapted S2 cells</td><td align="left" valign="top">Expression Systems</td><td align="left" valign="top">Cat# 94–005S</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">w1118</td><td align="left" valign="top">Perrimon lab</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">y,v; P{nos- phiC31\int.NLS}X; P{CaryP}attP40</td><td align="left" valign="top">Perrimon lab</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">y,w; P{nos- phiC31\int.NLS}X; P{CaryP}attP2</td><td align="left" valign="top">Perrimon lab</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">y,w; nos-Cas9/CyO</td><td align="left" valign="top">Perrimon lab</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">y,w; TM3, Sb/TM6,Tb</td><td align="left" valign="top">Perrimon lab</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; Gla/CyO</td><td align="left" valign="top">Perrimon lab</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; If/CyO; MKRS/TM6, Tb</td><td align="left" valign="top">Perrimon lab</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">Myo1A-Gal4, tub-Gal80<sup>ts</sup></td><td align="left" valign="top">Perrimon lab</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">Lpp-Gal4</td><td align="left" valign="top">Perrimon lab</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-NbVHH05-HA, w + attp2</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-NbVHH05-HA, w + attp40</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-Nb127D01-HA, w + attp2</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-Nb127D01-HA, w + attp40</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-NbVHH05-GFP, w + attp2</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-NbVHH05-GFP, w + attp40</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-Nb127D01-GFP, w + attp2</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-Nb127D01-GFP, w + attp40</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-BiP-NbVHH05-HA, w + attp2</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-BiP-NbVHH05-HA, w + attp40</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-BiP-Nb127D01-HA, w + attp2</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-BiP-Nb127D01-HA, w + attp40</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-BiP-NbVHH05-GFP, w + attp2</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-BiP-NbVHH05-GFP, w + attp40</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-BiP-Nb127D01-GFP, w + attp2</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-BiP-Nb127D01-GFP, w + attp40</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-BiP-VHH05-Upd2-127D01, w + attp40</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-VHH05-REPTOR-127D01, w + attp40</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">yw; UAS-VHH05-REPTOR-BP-C127D01, w + attp40</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">w; H2Av-3xVHH05/TM3, Sb</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="top">w; H2Av-3x127D01/TM3, Sb</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">See *Note</td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="top">TOP10 <italic>Escherichia coli</italic></td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">Cat# C404010</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="top">BL21 (DE3) <italic>Escherichia coli</italic></td><td align="left" valign="top">New England Biolabs</td><td align="left" valign="top">Cat# C25271</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">All oligos</td><td align="left" valign="top">This paper</td><td align="left" valign="top">See <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Photoshop</td><td align="left" valign="top">Adobe</td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014199">SCR_014199</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">ImageJ</td><td align="left" valign="top">NIH</td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Excel</td><td align="left" valign="top">Microsoft</td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016137">SCR_016137</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">GraphPad Prism6</td><td align="left" valign="top">GraphPad</td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Joystick Micromanipulator</td><td align="left" valign="top">NARISHIGE</td><td align="left" valign="top">Cat# MN-151</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">FemtoJet Microinjector</td><td align="left" valign="top">Eppendorf</td><td align="left" valign="top">Cat# LV41365120</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Garfunkel Nikon Ti2 Spinning Disk</td><td align="left" valign="top">Nikon</td><td align="left" valign="top">N/A</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Kimble Kontes pellet pestles</td><td align="left" valign="top">Millipore</td><td align="left" valign="top">Cat# Z359947</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Immobilon-P polyvinylidene fluoride (PVDF) membrane</td><td align="left" valign="top">Millipore</td><td align="left" valign="top">Cat# IPVH00010</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">ChemiDoc MP imaging system</td><td align="left" valign="top">Bio-Rad</td><td align="left" valign="top">Cat# 17001402</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Kodak M35 X-OMAT Automatic Processors</td><td align="left" valign="top">KODAK</td><td align="left" valign="top">Cat# RT-KP-M35A</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Hyperfilm ECL</td><td align="left" valign="top">Amersham</td><td align="left" valign="top">Cat# GE28-9068-35</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">4′,6-Diamidino-2-phenylindole (DAPI)</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">Cat# D1306 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2629482">AB_2629482</ext-link></td><td align="left" valign="top">(1 µg/ml)</td></tr></tbody></table><table-wrap-foot><fn><p>*Note: Further information and requests for resources and reagents used in this paper should be directed to and will be fulfilled by the Lead Contact, Norbert Perrimon (perrimon@genetics.med.harvard.edu.). Transgenic flies used to express these two nanobodies and plasmids used to express and prepare nanobodies, which have been submitted to public reagent resource centers, Bloomington Drosophila Stock Center, Drosophila Genomics Resource Center and Addgene.</p></fn></table-wrap-foot></table-wrap><sec id="s4-1"><title>Plasmid construction</title><p>Four types of vectors were used in this study: (1) pAW, that contains the fly actin5C promoter; (2) pWalium10, a UAS/Gal4 vector that contains a UAS promoter and mini-white selection marker (DGRC, 1470); (3) pMT (pMK-33GW, Ram Viswanatha); and (4) pET-26b (Novagen 69862). pAW-HGP-sortase is a pAW vector derivative with N-terminal BiP signal peptide/FLAG-tag, AarI-cloning site for Gibson or HiFi assembly, C-terminal purification tag with Sortase-tag and His-tag, and heat shock promoter-GFP-T2A-PuroR for stable cell line generation. pMT-HGP-v3 is a pMT vector derivative with N-terminal BiP signal peptide/FLAG-tag, AarI-cloning site for Gibson or HiFi assembly, C-terminal purification tag with Avi-tag and His-tag, and heat shock promoter-GFP-T2A-PuroR for stable cell line generation. pET-26b-Nb-GGA is a pET-26b derivative with BsaI Golden Gate Assembly cloning site flanked by pelB signal sequence and C-terminal ALFA- and His-tags.</p><p>Plasmid DNAs were constructed and amplified using standard protocols. Briefly, plasmids were linearized by restriction enzymes as described by the commercial vendor. PCR fragments were amplified using Phusion polymerase (New England Biolabs [NEB], M0530) or Q5 polymerase (NEB, M0494). Linearized plasmids and PCR fragments were gel purified using QIAquick columns (Qiagen, #28115) and joined using either Gibson assembly (NEB, E2611) or NEBuilder HiFi assembly (NEB, E2621). Reactions were transformed into chemically competent TOP10 <italic>E. coli</italic> (Invitrogen, C404010), plated and selected on lysogeny broth-agar plates with ampicillin (100 μg/ml) or kanamycin (50 μg/ml). Colony PCR was performed using Takara Taq polymerase (Clontech, TAKR001C). Plasmid DNA was isolated from cultured bacteria using QIAprep Spin Miniprep Kit (Qiagen, 27104). Plasmid sequences were confirmed by Sanger sequencing performed at the Dana-Farber/Harvard Cancer Center DNA Resource Core or Genewiz. Primers sequences are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-2"><title>pW10-nanobody variants</title><p>All UAS constructs were cloned into the pWalium10 (pW10) vector. For pW10-NbVHH05-HA, pW10-Nb127D01-HA, pW10-NbVHH05-GFP, pW10-Nb127D01-GFP, pW10-BiP-NbVHH05-HA, pW10-BiP-Nb127D01-HA, pW10-BiP-NbVHH05-GFP, and pW10-BiP-Nb127D01-GFP, pW10 was first linearized with EcoRI (NEB, R0101) and XbaI (NEB, R0145). NbVHH05 or Nb127D01 was cloned from pHEN6-VHH05 or pHEN6-127D01 (Ploegh lab). GFP was amplified from PXL-IE1-EGFP-nos-Cas9 (<xref ref-type="bibr" rid="bib35">Xu et al., 2020</xref>). PCR fragments were joined together with the digested pW10 backbone by Gibson assembly. HA and BiP were incorporated by adding overhanging sequences to the primers. For pW10-BiP-VHH05-Akh-127D01, pW10-BiP-VHH05-Dilp2-127D01, pW10-BiP-VHH05-Dilp8-127D01, pW10-BiP-VHH05-Pvf1-127D01, and pW10-BiP-VHH05-Upd2-127D01, pW10 was first digested with EcoRI and XbaI. A BiP-VHH05-127D01 fragment was made by annealing two oligos and ligated into the linearized pW10 to generate the intermediate vector, pW10-BiP-VHH05-BgIII-127D01. Next, PCR fragments of <italic>Akh, Dilp2, Dilp8, Pvf1,</italic> and <italic>Upd2</italic> were amplified from fly cDNAs and inserted into pW10-UAS-BiP-VHH05-127D01 linearized by BglII (NEB, R0144) by Gibson assembly. For pW10-127D01-REPTOR-bp-B-VHH05, pW10-127D01-REPTOR-bp-C-VHH05, and pW10-127D01-REPTOR-VHH05, pW10-BiP-VHH05-127D01 was digested with EcoRI and BglII to remove BiP-VHH05. VHH05-tag was introduced N-terminal of PCR fragments of <italic>REPTOR-bp-B, REPTOR-bp-C</italic> and <italic>REPTOR</italic> through overhanging primers. PCR fragments were inserted into pW10-127D01 (EcoRI and BglII digested) by Gibson assembly.</p></sec><sec id="s4-3"><title>pAW-nanobody/NanoTagged fluorophore variants</title><p>For pAW-NbVHH05-GFP, pAW-Nb127D01-GFP, pAW-NbVHH05-mCherry, pAW-Nb127D01-mCherry, pAW-H2B-mCherry-VHH05, pAW-H2B-mCherry-127D01, pAW-mito-mCherry-VHH05, pAW-mito-mCherry-127D01, pAW-CD8-mCherry-VHH05, pAW-CD8-mCherry-127D01, pAW-VHH05-H2B-mCherry, pAW-127D01-H2B-mCherry, pAW-BiP-NbVHH05-mCherry-KDEL, pAW-BiP-Nb127D01-mCherry-KDEL, pAW-CD8-NbVHH05-GFP, and pAW-CD8-Nb127D01-GFP, pAW was first linearized with NheI (NEB, R3131) and XbaI. NbVHH05-GFP and Nb127D01-GFP were amplified from pW10-NbVHH05-GFP and pW10-Nb127D01-GFP. <italic>CD8, mCherry</italic>, and <italic>CD8-mCherry</italic> were cloned from pQUASp-mCD8mCherry (Addgene, #46164). <italic>H2B-mCherry</italic> was cloned from pBac (3xP3-gTc’v; pUb:lox-mYFP-lox-H2BmCherry) (Addgene, #119064). <italic>mito-mCherry</italic> was cloned from pcDNA4TO-mito-mCherry-10xGCN4_v4 (Addgene, #60914). BiP-NbVHH05 or BiP-Nb127D01 fragments were cloned from pW10-UAS-BiP-NbVHH05-GFP, pW10-UAS-BiP-Nb127D01-GFP. PCR fragments were joined together with the digested pAW backbone by Gibson assembly. VHH05-, 127D01-tags, or KDEL sequences were incorporated in the N- or C-terminus by adding overhanging sequences to the primers. For pAW-CD8-VHH05-mCherry and pAW-CD8-127D01-mCherry, we first digested pAW-CD8-mCherry-VHH05 with NheI to obtain a linearized pAW-CD8 backbone. mCherry was amplified from pQUASp-mCD8mCherry. VHH05-tag or 127D01-tag was introduced into the N-terminal of PCR fragments with overhanging primer sequences. The NanoTag-mCherry PCR fragment was inserted into pAW-CD8 by Gibson assembly.</p></sec><sec id="s4-4"><title>pAW-HGP-BiP-GFP with 1x/2x/3x NanoTags</title><p>For pAW-HGP-BiP-GFP-VHH05, pAW-HGP-BiP-GFP-2xVHH05, pAW-HGP-BiP-GFP-3xVHH05, pAW-HGP-BiP-GFP-127D01, pAW-BiP-HGP-GFP-2x127D01, pAW-HGP-BiP-GFP-3x127D01, pAW-HGP-sortase was first linearized by AarI (Thermo Scientific ER1581). N-terminal GFP was amplified by PCR. C-terminal GFP with 1x/2x/3x NanoTags were prepared by gene synthesis (Twist Bioscience). PCR fragment and C-terminal GFP with NanoTags were joined together with the linearized pAW-HGP-sortase by NEBuilder HiFi assembly.</p></sec><sec id="s4-5"><title>pMT-HGP-V3-Nb127D01-hIgG, pMT-HGP-V3-NbVHH05-hIgG</title><p>For cloning of the inducible Nb127D01-hIgG and NbVHH05-hIgG expression vectors, the pMT-HGP-v3 vector was linearized by both AarI and NsiI-HF (NEB, R3127). hIgG Fc region was amplified from pCER243 (a gift of Aaron Ring at Yale). NbVHH05/Nb127D01 and hIgG PCR fragments were inserted into pMT-HGP-v3 (digested by AarI and Nsil-HF) by NEBuilder HiFi assembly.</p></sec><sec id="s4-6"><title>pET-26b-Nb127D01-ALFA-His, pET-26b-NbVHH05-ALFA-His, pET-26b-Nb127D01-HA-His, pET-26b-NbVHH05-HA-His</title><p>For cloning pET-26b-Nb127D01-ALFA-His and pET-26b-NbVHH05-ALFA-His, NbVHH05/Nb127D01 PCR fragments were cloned into pET-26b-Nb-GGA by BsaI-Golden Gate Assembly (NEB, E1601). To make pET-26b-Nb127D01-HA-His and pET-26b-NbVHH05-HA-His, NbVHH05/Nb127D01 PCR fragments with HA tag were cloned into pET-26b (NcoI, NEB, R3193 and XhoI, NEB, R0146 digested) by HiFi assembly.</p></sec><sec id="s4-7"><title>pScarless NanoTag vectors: pScarlessHD-C-3x127D01-DsRed, pScarlessHD-C-3xVHH05-DsRed, pScarlessHD-N-3x127D01-DsRed, pScarlessHD-N-3xVHH05-DsRed</title><p>3x127D01 or 3xVHH05 were cloned from pAW-HGP-BiP-GFP-3x127D01 or pAW-HGP-BiP-GFP-3xVHH05. 3xP3-DsRed was cloned from pScarlessHD-2xHA-DsRed (Addgene, 80822). Then, 3x127D01 or 3xVHH05 and 3xP3-DsRed PCR fragments were inserted into pScarlessHD-2xHA-DsRed backbone (EcoRI digested) by Gibson assembly.</p></sec><sec id="s4-8"><title>pScarlessHD-C-3x127D01-H2Av-DsRed, pScarlessHD-C-3xVHH05-H2Av-DsRed</title><p>pScarlessHD-C-3x127D01-DsRed and pScarlessHD-C-3xVHH05-DsRed were digested with EcoRI to obtain the pScarlessHD backbone and 3xP3-DsRed fragment. Upstream and downstream sequences of TAA at the C-terminus of the <italic>H2Av</italic> gene were cloned from <italic>yw; nos-Cas9/Cyo</italic> flies. Then, 3xP3-DsRed, upstream and downstream fragments were inserted into pScarlessHD backbone by Gibson assembly.</p></sec><sec id="s4-9"><title>pCFD3-H2Av-sgRNA</title><p>pCFD3 (Addgene, #49410) was digested with BbsI (NEB, R0539). sgRNA oligos following phosphorylation were annealed by T4PNK (NEB, M0201) and inserted into a digested pCFD3 backbone by T4 DNA ligase (NEB, M0202).</p></sec><sec id="s4-10"><title>Cell transfection</title><p><italic>Drosophila</italic> S2<italic>R</italic>+ cells (DGRC, 150) were cultured at 25°C in Schneider’s media (Thermo Fisher Scientific, 21720–024) with 10% fetal bovine serum (Sigma, A3912) and 50 U/ml penicillin-streptomycin (Thermo Fisher Scientific, 15070–063). S2<italic>R</italic>+ cells were transfected using Effectene (Qiagen, 301427) following the manufacturer’s instructions. A total of 200 ng of plasmid DNA per well was transfected in 24-well plates. The culture medium was replaced 24 hr after transfection.</p><p>To produce secreted GFP proteins with 1x/2x/3x NanoTags and nanobodies with hIgG, ESF921-adapted S2 cells (Expression Systems, 94–005S) were transfected using PEI transfection methods and cultured in protein-free ESF921 media (Expression Systems, 96–001). For six-well plate transfection, 2.4 µg of DNA and 7.4 µg of PEI were mixed in 300 µl of ESF921 media for 15–30 min and added to 2.7 ml of S2 cell culture (2E6 cells/ml, final cell density). Alternatively, 50 ml suspension cells cultured in 250 ml flask were transfected using the same proportion. On day 2 from transfection, protein expression was induced with 700 µM CuSO4 for 5 days. Cleared conditioned media were collected after centrifugation and directly used for immunostaining, western blot, and immunoprecipitation.</p></sec><sec id="s4-11"><title>Fly strains and generating transgenic flies</title><p>Fly husbandry and crosses were performed under standard conditions at 25°C. Injections were carried in-house. Fly strains used to generate transgenic lines were attP lines: attP40 (<italic>y,v; P{nos- phiC31\int.NLS}X; P{CaryP}attP40</italic>) and attP2 (<italic>y,w; P{nos- phiC31\int.NLS}X; P{CaryP}attP2</italic>). Fly strains used to generate KI lines were <italic>y,w; nos-Cas9/CyO</italic>. For balancing chromosomes, fly stocks <italic>y,w; TM3, Sb/TM6,Tb</italic>, <italic>yw; Gla/CyO</italic>, <italic>yw; If/CyO; MKRS/TM6,Tb</italic> were used. All lines recovered were homozygous viable. Fly stocks are from the Perrimon fly stock unless stated otherwise. Other fly stocks used in this study were <italic>Lpp-Gal4</italic> (Hong-Wen Tang) and <italic>Myo1A-Gal4, tub-Gal80<sup>ts</sup></italic> (Afroditi Petsakou).</p><list list-type="simple"><list-item><p>Transgenic flies generated in this study are as follows: yw; UAS-NbVHH05-HA, w + attP2 yw; UAS-NbVHH05-HA, w + attP40 yw; UAS-Nb127D01-HA, w + attP2</p></list-item><list-item><p>yw; UAS-Nb127D01-HA, w+ attP40 yw; UAS-NbVHH05-GFP, w+ attP2</p></list-item><list-item><p>yw; UAS-NbVHH05-GFP, w+ attP40 yw; UAS-Nb127D01-GFP, w+ attP2</p></list-item><list-item><p>yw; UAS-Nb127D01-GFP, w+ attP40 yw; UAS-BiP-NbVHH05-HA, w+ attP2</p></list-item><list-item><p>yw; UAS-BiP-NbVHH05-HA, w+ attP40 yw; UAS-BiP-Nb127D01-HA, w+ attP2</p></list-item><list-item><p>yw; UAS-BiP-Nb127D01-HA, w+ attP40</p></list-item><list-item><p>yw; UAS-BiP-NbVHH05-GFP, w+ attP2</p></list-item><list-item><p>yw; UAS-BiP-NbVHH05-GFP, w+ attP40 yw; UAS-BiP-Nb127D01-GFP, w+ attP2</p></list-item><list-item><p>yw; UAS-BiP-Nb127D01-GFP, w+ attP40 yw; UAS-BiP-VHH05-Upd2-127D01, w+ attP40</p></list-item><list-item><p>yw; UAS-VHH05-REPTOR-127D01, w+ attP40</p></list-item><list-item><p>yw; UAS-VHH05-REPTOR-BP-C-127D01, w+ attP40</p></list-item><list-item><p>w; H2Av-3xVHH05/TM3, Sb w; H2Av-3x127D01/TM3, Sb</p></list-item></list><p>Transgenic flies were generated by phiC31 integration of attB-containing plasmids into either attP40 or attP2 landing sites. Briefly, plasmid DNA was purified on QIAquick columns and eluted in injection buffer (100 μM NaPO<sub>4</sub>, 5 mM KCl) at a concentration of 200–400 ng/μl. Plasmid DNA was injected into ∼100 fertilized embryos (<italic>y,v nos-phiC31int; attP40</italic> or <italic>y,w nos-phiC31int; attP2</italic>) through microinjection handle (NARISHIGE, Japan) with pressure control (FemtoJet, Eppendorf). The progeny was outcrossed to screen for transgenic founder progeny and the UAS insertions were isolated by screening for white+ eye color.</p><p>To generate KI flies, donor and sgRNA plasmids were mixed together and were injected into ∼100 fertilized embryos (<italic>y,w; nos-Cas9/CyO</italic>). Transformed lines were isolated using a DsRed marker. To remove the DsRed cassette, transformed lines were crossed to a line expressing PBac transposase (BL #8285). Resulting lines were sequenced to confirm the insertion of 3x127D01-tag or 3xVHH05-tag to the C-terminal of the <italic>H2Av</italic> or <italic>Dilp2</italic> gene.</p></sec><sec id="s4-12"><title>Targeted integration analysis</title><p>Genomic DNA was extracted from the DsRed2-positive G1 adult animals by standard sodium dodecyl sulfate (SDS) lysis-phenol buffer after incubation with proteinase K (Roche, 3115879001), followed by RNase A (Thermo Fisher Scientific, EN0531) treatment and purification. The 5’- and 3’-end junction fragments at the integration event were cloned separately and sequenced. PCR conditions included 2 min of denaturation at 95°C; 30 cycles of 1 min at 95°C, 30 s at 55°C and 1 min at 72°C; followed by a final extension at 72°C for 10 min by using Takara Taq polymerase (Clontech, #TAKR001). To confirm the removal of the DsRed cassette, the genomic DNA was extracted by the same method and PCR conditions included 2 min of denaturation at 95°C; 30 cycles of 1 min at 95°C, 30 s at 55°C and 30 s at 72°C; followed by a final extension at 72°C for 10 min. PCR products were subcloned into the pJET-1.2 vector (Fermentas, #K1231) and sequenced. Primer sequences are listed in the <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-13"><title>Rapamycin treatment</title><p>For rapamycin treatment, rapamycin (LC Laboratories, R-5000) was dissolved in DMSO and mixed into the media when preparing food vials. The rapamycin dose was 50 µM.</p></sec><sec id="s4-14"><title>Nanobody purification</title><p>Nanobody expression vectors with C-terminal ALFA-tag or HA-tag for bacterial expression and purification were cloned into pET-26b-Nb-GGA or pET-26b by Golden-Gate assembly or Gibson cloning, respectively. After transformation with BL21 (DE3) competent cells (NEB, C25271), overnight cultures were inoculated in LK media and incubated at 37°C until the OD600 approached ~0.6. Then, 0.1 mM IPTG was added and cultures were placed at 15°C for overnight. After centrifugation, the cell pellet was collected and resuspended in B-PER II Bacterial Protein Extraction Reagent (Thermo Scientific, 78260). After 30 min incubation with rotation, an additional 19× volume of TBS was added and further incubated with rotation. Cleared supernatants were collected after centrifugation at 20,000<italic>g</italic> and 4 °C for 15 min and used for His-tag purification. Dialyzed His-tag purified nanobody fractions were diluted at 0.2 mg/ml concentration, which were directly used for immunostainings and western blots. To generate fluorescent-labeled nanobodies, Mix-n-Stain CF 555 Antibody Labeling Kit and Mix-n-Stain CF 647 Antibody Labeling Kit (Sigma-Aldrich, MX555S100 and MX647S100) were used according to the manufacturer’s protocol.</p><p>Nanobodies equipped with an LPETGG motif and a His-tag at their C-terminus were functionalized with triglycine containing probes using Sortase 5 M as previously described (<xref ref-type="bibr" rid="bib9">Cheloha et al., 2019</xref>). Briefly, LPETGG motif and His-tag at the C-terminus of nanobodies were replaced with fluorophore or biotin contained in triglycine probes by sortagging reaction. Ni-NTA resin (EMD Millipore, 70691–3) was used to remove unreacted His-tagged nanobodies and His-tagged Sortase 5 M enzyme, and the flow-through (sortase-based labeled nanobodies) was collected. The flow-through was applied to PD-10 column (GE Healthcare, GE17-0851-01) to remove excess triglycine probes.</p></sec><sec id="s4-15"><title>Immunostaining and imaging analysis</title><p><italic>Drosophila</italic> fat body and midguts from adult females were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) at room temperature for 1 hr, incubated for 1 hr in blocking buffer (5% normal donkey serum, 0.3% Triton X-100, 0.1% bovine serum albumin [BSA] in PBS), and stained with primary antibodies overnight at 4°C in PBST (0.3% Triton X-100, 0.1% BSA in PBS). S2<italic>R</italic>+ cells were fixed in 4% paraformaldehyde in PBS at room temperature for 30 min, incubated for 1 hr in blocking buffer, and stained with primary antibodies for 2–3 hr at room temperature in PBST. The primary antibodies and their dilutions used are: NbVHH05-ALFA (1:500), NbVHH05-HA (1:500), NbVHH05-hIgG (1:20, S2 cell culture media), NbVHH05-555 (1:500), Nb127D01-ALFA (1:500), Nb127D01-HA (1:500), Nb127D01-hIgG (1:20, S2 cell culture media), Nb127D01-647 (1:500), mouse anti-GFP (Invitrogen, A11120; 1:300), rat anti-HA (Sigma-Aldrich, 3F10; 1:1000), rabbit anti-Dilp2 (0.5 µg/ml) (<xref ref-type="bibr" rid="bib27">Park et al., 2014</xref> ). After primary antibody incubation, the fat body and midguts or S2<italic>R</italic>+ cells were washed three times with PBST, stained with 4′,6-diamidino-2-phenylindole (DAPI) (1:2000 dilution) and Alexa Fluor-conjugated donkey-anti-mouse, donkey-anti-rabbit and mouse-anti-hIgG secondary antibodies (Molecular Probes, 1:1000), or NbALFA-Atto647 (NanoTag Biotechnologies, N1502-At647N-L; 1:500) Goat Anti-Alpaca IgG-647 (Jackson ImmunoResearch, 128-605-230; 1:500) in PBST at 22°C for 2 hr, washed three times with PBST, and mounted in Vectashield medium.</p><p>All images of the posterior midgut or S2<italic>R</italic>+ cells that are presented in this study are confocal images captured with a Nikon Ti2 Spinning Disk confocal microscope. Z-stacks of 5–20 images covering one layer of the epithelium from the apical to the basal side were obtained, adjusted, and assembled using NIH Fiji (ImageJ), and shown as a maximum projection.</p></sec><sec id="s4-16"><title>Western blots</title><p>Cultured cells were harvested 3 days after transfection. For fly, six to eight larval fat bodies or three female midguts per group were dissected in PBS, placed in 50 μl lysis buffer (Pierce, #87788) with 2× protease and phosphatase inhibitor cocktail (Pierce, #78440) and 2 mM trypsin inhibitor benzamidine (Sigma-Aldrich, #434760), and homogenized using Kimble Kontes pellet pestles (Millipore, Z359947). Protein lysates were incubated in 2xSDS sample buffer (Thermo Scientific, #39001) containing 5% 2-mercaptoethanol at 100°C for 10 min, ran on a 4–20% polyacrylamide gel (Bio-Rad, #4561096), and transferred to an Immobilon-P polyvinylidene fluoride (PVDF) membrane (Millipore, IPVH00010). The membrane was blocked by 5% BSA or 5% skim milk in 1× Tris-buffered saline (TBS) containing 0.1% Tween-20 (TBST) at room temperature for 30 min. The following primary antibodies were used: anti-tubulin (Sigma, T5168, 1:10,000), rabbit anti-GFP (Molecular Probes, A-6455; 1:10,000) and anti-FLAG M1 (Sigma, F3040, 1:5000), rat anti-HA (Sigma-Aldrich, 3F10; 1:10,000), NbVHH05 (0.2 mg/ml, 1:5000, or 1:100~1:100,000 used in concentration gradient test), Nb127D01 (0.2 mg/ml, 1:5000, or 1:100~1:100,000 used in concentration gradient test), NbVHH05-hIgG (1:100, S2 cell culture media), Nb127D01-hIgG (1:100, S2 cell culture media) in blocking solution. After washing with TBST, signals were detected with enhanced chemiluminescence (ECL) reagents (Amersham, RPN2209; Pierce, #34095) or fluorescent secondary antibodies information. Western blot images were acquired by Bio-Rad ChemiDoc MP or X-ray film exposure.</p></sec><sec id="s4-17"><title>Immunoprecipitation</title><p>For immunoprecipitation using ALFA-tagged nanobodies (NbVHH05-ALFA and Nb127D01-ALFA), His-tag purified nanobodies from bacteria were incubated with ALFA Selector ST resin (Nanotag Biotechnologies, N1511) at room temperature for 1 hr. The resin was washed with Pierce IP lysis buffer (Thermo Scientific, 87787) (3×) and incubated with S2 cell culture media containing secreted GFP proteins with 3xVHH05-tag and 3x127D01 tag at 4°C for 1 hr. After washing in IP lysis buffer (4×), proteins were eluted in 2× sample buffer.</p><p>For immunoprecipitation using hIgG-formatted nanobody (Nb127D01-hIgG), Protein A magnetic beads (Bio-Rad, 1614013) were incubated with S2 cell culture media containing Nb127D01-hIgG at room temperature for 1 hr. After washing in IP lysis buffer (3×), beads were incubated with the conditioned media containing secreted GFP proteins 3x127D01 tag at 4°C for 1 hr. After washing in IP lysis buffer (4×), proteins were eluted in 2× sample buffer.</p></sec><sec id="s4-18"><title>ELISA</title><p>GFP fused at its C-terminus with a peptide corresponding to the extracellular portion of human CXCR2 (full-length, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), produced through sortagging, was immobilized on Nunc 96-well Maxisorp flat bottom plates (100 ng/well). After immobilization, wells were blocked using a solution of BSA in PBS (5% w/v). Nb127D01 conjugated with biotin (20 nM) was mixed with peptides corresponding to full-length CXCR2 extracellular domain or two fragments at varying concentrations. These solutions were then added to plates with immobilized GFP-CXCR2 and incubated for 1 hr. These solutions were discarded from the plates, the plates were washed with PBS containing 0.05% Tween-20, and the amount of Nb127D01-biotin bound to the plate was quantified through the addition of streptavidin-HRP (Thermo Fisher, N100), washing, and the addition of tetramethylbenzidine-containing solution (Thermo Fisher, N301).</p></sec><sec id="s4-19"><title>Trehalose assay</title><p>Whole-body trehalose levels were measured from five to six groups (each group has four female flies). Fly samples were homogenized with 300 µl TBST buffer (5 mM Tris-HCl [pH 6.6], 137 mM NaCl, 2.7 mM KCl, 0.1% TritonX-100), heated at 75°C for 10 min, and centrifuged at 3000 <italic>g</italic> for 1 min. Ten µl of supernatant was added to 100 µl glucose assay reagent (Megazyme; K-GLUC) with or without trehalose (1:500; Megazyme; E-TREH) at 37°C for 30 min. The absorbance at 340 nm was measured on a Molecular Devices SpectraMax Paradigm plate reader. The trehalose concentration in the sample was determined by subtracting the glucose concentration from the total sugar concentration.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Formal analysis, Investigation, Methodology, Resources, Validation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Visualization</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation, Methodology, Validation</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Investigation, Methodology, Validation</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Investigation, Resources</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Data curation, Project administration, Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Data curation, Methodology, Project administration, Resources, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Data curation, Funding acquisition, Methodology, Resources, Software, Supervision, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Data curation, Funding acquisition, Methodology, Project administration, Resources, Supervision, Validation, Writing – review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Primers used in this study.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-74326-supp1-v2.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-74326-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank the assistance provided by the Microscopy Resources on the North Quad (MicRoN) core at Harvard Medical School, Christians Villalta for help with the generation of transgenic flies and Hong-Wen Tang for help with the Western blots. We thank Seung K Kim for providing the anti-Dilp2 antibody. This work was supported by NIH NIGMS P41 GM132087. AK is supported by Postdoctoral Fellowship Program (Nurturing Next-generation Researchers) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2021R1A6A3A14039622). JSSL is supported by a Croucher fellowship for Postdoctoral Research from the Croucher Foundation. NP is an investigator of Howard Hughes Medical Institute.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar</surname><given-names>G</given-names></name><name><surname>Matsuda</surname><given-names>S</given-names></name><name><surname>Vigano</surname><given-names>MA</given-names></name><name><surname>Affolter</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Using Nanobodies to Study Protein Function in Developing Organisms</article-title><source>Antibodies (Basel, Switzerland)</source><volume>8</volume><elocation-id>16</elocation-id><pub-id pub-id-type="doi">10.3390/antib8010016</pub-id><pub-id pub-id-type="pmid">31544822</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anzalone</surname><given-names>AV</given-names></name><name><surname>Randolph</surname><given-names>PB</given-names></name><name><surname>Davis</surname><given-names>JR</given-names></name><name><surname>Sousa</surname><given-names>AA</given-names></name><name><surname>Koblan</surname><given-names>LW</given-names></name><name><surname>Levy</surname><given-names>JM</given-names></name><name><surname>Chen</surname><given-names>PJ</given-names></name><name><surname>Wilson</surname><given-names>C</given-names></name><name><surname>Newby</surname><given-names>GA</given-names></name><name><surname>Raguram</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Search-and-replace genome editing without double-strand breaks or donor DNA</article-title><source>Nature</source><volume>576</volume><fpage>149</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1711-4</pub-id><pub-id pub-id-type="pmid">31634902</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boersma</surname><given-names>S</given-names></name><name><surname>Khuperkar</surname><given-names>D</given-names></name><name><surname>Verhagen</surname><given-names>BMP</given-names></name><name><surname>Sonneveld</surname><given-names>S</given-names></name><name><surname>Grimm</surname><given-names>JB</given-names></name><name><surname>Lavis</surname><given-names>LD</given-names></name><name><surname>Tanenbaum</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Multi-Color Single-Molecule Imaging Uncovers Extensive Heterogeneity in mRNA Decoding</article-title><source>Cell</source><volume>178</volume><fpage>458</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.001</pub-id><pub-id pub-id-type="pmid">31178119</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosch</surname><given-names>JA</given-names></name><name><surname>Birchak</surname><given-names>G</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Precise genome engineering in <italic>Drosophila</italic> using prime editing</article-title><source>PNAS</source><volume>118</volume><elocation-id>e2021996118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2021996118</pub-id><pub-id pub-id-type="pmid">33443210</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>ME</given-names></name><name><surname>Dombrecht</surname><given-names>B</given-names></name><name><surname>Manini</surname><given-names>J</given-names></name><name><surname>Willis</surname><given-names>J</given-names></name><name><surname>Vlerick</surname><given-names>D</given-names></name><name><surname>De Taeye</surname><given-names>S</given-names></name><name><surname>Van den Heede</surname><given-names>K</given-names></name><name><surname>Roobrouck</surname><given-names>A</given-names></name><name><surname>Grot</surname><given-names>E</given-names></name><name><surname>Kent</surname><given-names>TC</given-names></name><name><surname>Laeremans</surname><given-names>T</given-names></name><name><surname>Steffensen</surname><given-names>S</given-names></name><name><surname>Van Heeke</surname><given-names>G</given-names></name><name><surname>Brown</surname><given-names>Z</given-names></name><name><surname>Charlton</surname><given-names>SJ</given-names></name><name><surname>Cromie</surname><given-names>KD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Potent and efficacious inhibition of CXCR2 signaling by biparatopic nanobodies combining two distinct modes of action</article-title><source>Molecular Pharmacology</source><volume>87</volume><fpage>251</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1124/mol.114.094821</pub-id><pub-id pub-id-type="pmid">25468882</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broughton</surname><given-names>S</given-names></name><name><surname>Alic</surname><given-names>N</given-names></name><name><surname>Slack</surname><given-names>C</given-names></name><name><surname>Bass</surname><given-names>T</given-names></name><name><surname>Ikeya</surname><given-names>T</given-names></name><name><surname>Vinti</surname><given-names>G</given-names></name><name><surname>Tommasi</surname><given-names>AM</given-names></name><name><surname>Driege</surname><given-names>Y</given-names></name><name><surname>Hafen</surname><given-names>E</given-names></name><name><surname>Partridge</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Reduction of DILP2 in <italic>Drosophila</italic> triages a metabolic phenotype from lifespan revealing redundancy and compensation among DILPs</article-title><source>PLOS ONE</source><volume>3</volume><elocation-id>e3721</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0003721</pub-id><pub-id pub-id-type="pmid">19005568</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caussinus</surname><given-names>E</given-names></name><name><surname>Kanca</surname><given-names>O</given-names></name><name><surname>Affolter</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Fluorescent fusion protein knockout mediated by anti-GFP nanobody</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>19</volume><fpage>117</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1038/nsmb.2180</pub-id><pub-id pub-id-type="pmid">22157958</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caussinus</surname><given-names>E</given-names></name><name><surname>Affolter</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>deGradFP: A System to Knockdown GFP-Tagged Proteins</article-title><source>Methods in Molecular Biology (Clifton, N.J.)</source><volume>1478</volume><fpage>177</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-6371-3_9</pub-id><pub-id pub-id-type="pmid">27730581</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheloha</surname><given-names>RW</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Bousbaine</surname><given-names>D</given-names></name><name><surname>Woodham</surname><given-names>AW</given-names></name><name><surname>Perrin</surname><given-names>P</given-names></name><name><surname>Volarić</surname><given-names>J</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Internalization of Influenza Virus and Cell Surface Proteins Monitored by Site-Specific Conjugation of Protease-Sensitive Probes</article-title><source>ACS Chemical Biology</source><volume>14</volume><fpage>1836</fpage><lpage>1844</lpage><pub-id pub-id-type="doi">10.1021/acschembio.9b00493</pub-id><pub-id pub-id-type="pmid">31348637</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheloha</surname><given-names>RW</given-names></name><name><surname>Harmand</surname><given-names>TJ</given-names></name><name><surname>Wijne</surname><given-names>C</given-names></name><name><surname>Schwartz</surname><given-names>TU</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Exploring cellular biochemistry with nanobodies</article-title><source>The Journal of Biological Chemistry</source><volume>295</volume><fpage>15307</fpage><lpage>15327</lpage><pub-id pub-id-type="doi">10.1074/jbc.REV120.012960</pub-id><pub-id pub-id-type="pmid">32868455</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Genst</surname><given-names>EJ</given-names></name><name><surname>Guilliams</surname><given-names>T</given-names></name><name><surname>Wellens</surname><given-names>J</given-names></name><name><surname>O’Day</surname><given-names>EM</given-names></name><name><surname>Waudby</surname><given-names>CA</given-names></name><name><surname>Meehan</surname><given-names>S</given-names></name><name><surname>Dumoulin</surname><given-names>M</given-names></name><name><surname>Hsu</surname><given-names>S-TD</given-names></name><name><surname>Cremades</surname><given-names>N</given-names></name><name><surname>Verschueren</surname><given-names>KHG</given-names></name><name><surname>Pardon</surname><given-names>E</given-names></name><name><surname>Wyns</surname><given-names>L</given-names></name><name><surname>Steyaert</surname><given-names>J</given-names></name><name><surname>Christodoulou</surname><given-names>J</given-names></name><name><surname>Dobson</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Structure and properties of a complex of α-synuclein and a single-domain camelid antibody</article-title><source>Journal of Molecular Biology</source><volume>402</volume><fpage>326</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2010.07.001</pub-id><pub-id pub-id-type="pmid">20620148</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>T</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Berger</surname><given-names>D</given-names></name><name><surname>Gmeiner</surname><given-names>C</given-names></name><name><surname>Cho</surname><given-names>J</given-names></name><name><surname>Schalek</surname><given-names>R</given-names></name><name><surname>Ploegh</surname><given-names>H</given-names></name><name><surname>Lichtman</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nanobody immunostaining for correlated light and electron microscopy with preservation of ultrastructure</article-title><source>Nature Methods</source><volume>15</volume><fpage>1029</fpage><lpage>1032</lpage><pub-id pub-id-type="doi">10.1038/s41592-018-0177-x</pub-id><pub-id pub-id-type="pmid">30397326</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fornasiero</surname><given-names>EF</given-names></name><name><surname>Opazo</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Super-resolution imaging for cell biologists: concepts, applications, current challenges and developments</article-title><source>BioEssays</source><volume>37</volume><fpage>436</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1002/bies.201400170</pub-id><pub-id pub-id-type="pmid">25581819</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Götzke</surname><given-names>H</given-names></name><name><surname>Kilisch</surname><given-names>M</given-names></name><name><surname>Martínez-Carranza</surname><given-names>M</given-names></name><name><surname>Sograte-Idrissi</surname><given-names>S</given-names></name><name><surname>Rajavel</surname><given-names>A</given-names></name><name><surname>Schlichthaerle</surname><given-names>T</given-names></name><name><surname>Engels</surname><given-names>N</given-names></name><name><surname>Jungmann</surname><given-names>R</given-names></name><name><surname>Stenmark</surname><given-names>P</given-names></name><name><surname>Opazo</surname><given-names>F</given-names></name><name><surname>Frey</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The ALFA-tag is a highly versatile tool for nanobody-based bioscience applications</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>4403</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-12301-7</pub-id><pub-id pub-id-type="pmid">31562305</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harmansa</surname><given-names>S</given-names></name><name><surname>Hamaratoglu</surname><given-names>F</given-names></name><name><surname>Affolter</surname><given-names>M</given-names></name><name><surname>Caussinus</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dpp spreading is required for medial but not for lateral wing disc growth</article-title><source>Nature</source><volume>527</volume><fpage>317</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1038/nature15712</pub-id><pub-id pub-id-type="pmid">26550827</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harmansa</surname><given-names>S</given-names></name><name><surname>Alborelli</surname><given-names>I</given-names></name><name><surname>Bieli</surname><given-names>D</given-names></name><name><surname>Caussinus</surname><given-names>E</given-names></name><name><surname>Affolter</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A nanobody-based toolset to investigate the role of protein localization and dispersal in <italic>Drosophila</italic></article-title><source>eLife</source><volume>6</volume><elocation-id>e22549</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.22549</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harmansa</surname><given-names>S</given-names></name><name><surname>Affolter</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Protein binders and their applications in developmental biology</article-title><source>Development (Cambridge, England)</source><volume>145</volume><elocation-id>dev148874</elocation-id><pub-id pub-id-type="doi">10.1242/dev.148874</pub-id><pub-id pub-id-type="pmid">29374062</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helma</surname><given-names>J</given-names></name><name><surname>Cardoso</surname><given-names>MC</given-names></name><name><surname>Muyldermans</surname><given-names>S</given-names></name><name><surname>Leonhardt</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Nanobodies and recombinant binders in cell biology</article-title><source>The Journal of Cell Biology</source><volume>209</volume><fpage>633</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1083/jcb.201409074</pub-id><pub-id pub-id-type="pmid">26056137</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamb</surname><given-names>AM</given-names></name><name><surname>Walker</surname><given-names>EA</given-names></name><name><surname>Wittkopp</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Tools and strategies for scarless allele replacement in <italic>Drosophila</italic> using CRISPR/Cas9</article-title><source>Fly</source><volume>11</volume><fpage>53</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1080/19336934.2016.1220463</pub-id><pub-id pub-id-type="pmid">27494619</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li-Kroeger</surname><given-names>D</given-names></name><name><surname>Kanca</surname><given-names>O</given-names></name><name><surname>Lee</surname><given-names>PT</given-names></name><name><surname>Cowan</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>MT</given-names></name><name><surname>Jaiswal</surname><given-names>M</given-names></name><name><surname>Salazar</surname><given-names>JL</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Zuo</surname><given-names>Z</given-names></name><name><surname>Bellen</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>An expanded toolkit for gene tagging based on MiMIC and scarless CRISPR tagging in <italic>Drosophila</italic></article-title><source>eLife</source><volume>7</volume><elocation-id>e38709</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.38709</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>L</given-names></name><name><surname>Kokoza</surname><given-names>VA</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Aksoy</surname><given-names>E</given-names></name><name><surname>Raikhe</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MicroRNA-277 targets insulin-like peptides 7 and 8 to control lipid metabolism and reproduction in Aedes aegypti mosquitoes</article-title><source>PNAS</source><volume>114</volume><fpage>E8017</fpage><lpage>E8024</lpage><pub-id pub-id-type="doi">10.1073/pnas.1710970114</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>J</given-names></name><name><surname>Cheloha</surname><given-names>RW</given-names></name><name><surname>McCaul</surname><given-names>N</given-names></name><name><surname>Sun</surname><given-names>Z-YJ</given-names></name><name><surname>Wagner</surname><given-names>G</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A nanobody that recognizes a 14-residue peptide epitope in the E2 ubiquitin-conjugating enzyme UBC6e modulates its activity</article-title><source>Molecular Immunology</source><volume>114</volume><fpage>513</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2019.08.008</pub-id><pub-id pub-id-type="pmid">31518855</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikhaylova</surname><given-names>M</given-names></name><name><surname>Cloin</surname><given-names>BMC</given-names></name><name><surname>Finan</surname><given-names>K</given-names></name><name><surname>van den Berg</surname><given-names>R</given-names></name><name><surname>Teeuw</surname><given-names>J</given-names></name><name><surname>Kijanka</surname><given-names>MM</given-names></name><name><surname>Sokolowski</surname><given-names>M</given-names></name><name><surname>Katrukha</surname><given-names>EA</given-names></name><name><surname>Maidorn</surname><given-names>M</given-names></name><name><surname>Opazo</surname><given-names>F</given-names></name><name><surname>Moutel</surname><given-names>S</given-names></name><name><surname>Vantard</surname><given-names>M</given-names></name><name><surname>Perez</surname><given-names>F</given-names></name><name><surname>van Bergen en Henegouwen</surname><given-names>PMP</given-names></name><name><surname>Hoogenraad</surname><given-names>CC</given-names></name><name><surname>Ewers</surname><given-names>H</given-names></name><name><surname>Kapitein</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Resolving bundled microtubules using anti-tubulin nanobodies</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>7933</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms8933</pub-id><pub-id pub-id-type="pmid">26260773</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohr</surname><given-names>SE</given-names></name><name><surname>Tattikota</surname><given-names>SG</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Zirin</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Methods and tools for spatial mapping of single-cell RNAseq clusters in <italic>Drosophila</italic></article-title><source>Genetics</source><volume>217</volume><elocation-id>iyab019</elocation-id><pub-id pub-id-type="doi">10.1093/genetics/iyab019</pub-id><pub-id pub-id-type="pmid">33713129</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morin</surname><given-names>X</given-names></name><name><surname>Daneman</surname><given-names>R</given-names></name><name><surname>Zavortink</surname><given-names>M</given-names></name><name><surname>Chia</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A protein trap strategy to detect GFP-tagged proteins expressed from their endogenous loci in <italic>Drosophila</italic></article-title><source>PNAS</source><volume>98</volume><fpage>15050</fpage><lpage>15055</lpage><pub-id pub-id-type="doi">10.1073/pnas.261408198</pub-id><pub-id pub-id-type="pmid">11742088</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumüller</surname><given-names>RA</given-names></name><name><surname>Wirtz-Peitz</surname><given-names>F</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kwon</surname><given-names>Y</given-names></name><name><surname>Buckner</surname><given-names>M</given-names></name><name><surname>Hoskins</surname><given-names>RA</given-names></name><name><surname>Venken</surname><given-names>KJT</given-names></name><name><surname>Bellen</surname><given-names>HJ</given-names></name><name><surname>Mohr</surname><given-names>SE</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Stringent analysis of gene function and protein-protein interactions using fluorescently tagged genes</article-title><source>Genetics</source><volume>190</volume><fpage>931</fpage><lpage>940</lpage><pub-id pub-id-type="doi">10.1534/genetics.111.136465</pub-id><pub-id pub-id-type="pmid">22174071</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Alfa</surname><given-names>RW</given-names></name><name><surname>Topper</surname><given-names>SM</given-names></name><name><surname>Kim</surname><given-names>GES</given-names></name><name><surname>Kockel</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A genetic strategy to measure circulating <italic>Drosophila</italic> insulin reveals genes regulating insulin production and secretion</article-title><source>PLOS Genetics</source><volume>10</volume><elocation-id>e1004555</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004555</pub-id><pub-id pub-id-type="pmid">25101872</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarov</surname><given-names>M</given-names></name><name><surname>Barz</surname><given-names>C</given-names></name><name><surname>Jambor</surname><given-names>H</given-names></name><name><surname>Hein</surname><given-names>MY</given-names></name><name><surname>Schmied</surname><given-names>C</given-names></name><name><surname>Suchold</surname><given-names>D</given-names></name><name><surname>Stender</surname><given-names>B</given-names></name><name><surname>Janosch</surname><given-names>S</given-names></name><name><surname>K J</surname><given-names>VV</given-names></name><name><surname>Krishnan</surname><given-names>RT</given-names></name><name><surname>Krishnamoorthy</surname><given-names>A</given-names></name><name><surname>Ferreira</surname><given-names>IRS</given-names></name><name><surname>Ejsmont</surname><given-names>RK</given-names></name><name><surname>Finkl</surname><given-names>K</given-names></name><name><surname>Hasse</surname><given-names>S</given-names></name><name><surname>Kämpfer</surname><given-names>P</given-names></name><name><surname>Plewka</surname><given-names>N</given-names></name><name><surname>Vinis</surname><given-names>E</given-names></name><name><surname>Schloissnig</surname><given-names>S</given-names></name><name><surname>Knust</surname><given-names>E</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name><name><surname>Ramaswami</surname><given-names>M</given-names></name><name><surname>VijayRaghavan</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Schnorrer</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A genome-wide resource for the analysis of protein localisation in <italic>Drosophila</italic></article-title><source>eLife</source><volume>5</volume><elocation-id>e12068</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.12068</pub-id><pub-id pub-id-type="pmid">26896675</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanenbaum</surname><given-names>ME</given-names></name><name><surname>Gilbert</surname><given-names>LA</given-names></name><name><surname>Qi</surname><given-names>LS</given-names></name><name><surname>Weissman</surname><given-names>JS</given-names></name><name><surname>Vale</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A protein-tagging system for signal amplification in gene expression and fluorescence imaging</article-title><source>Cell</source><volume>159</volume><fpage>635</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.09.039</pub-id><pub-id pub-id-type="pmid">25307933</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiebe</surname><given-names>M</given-names></name><name><surname>Lutz</surname><given-names>M</given-names></name><name><surname>De La Garza</surname><given-names>A</given-names></name><name><surname>Buechling</surname><given-names>T</given-names></name><name><surname>Boutros</surname><given-names>M</given-names></name><name><surname>Teleman</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>REPTOR and REPTOR-BP Regulate Organismal Metabolism and Transcription Downstream of TORC1</article-title><source>Developmental Cell</source><volume>33</volume><fpage>272</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2015.03.013</pub-id><pub-id pub-id-type="pmid">25920570</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traenkle</surname><given-names>B</given-names></name><name><surname>Emele</surname><given-names>F</given-names></name><name><surname>Anton</surname><given-names>R</given-names></name><name><surname>Poetz</surname><given-names>O</given-names></name><name><surname>Haeussler</surname><given-names>RS</given-names></name><name><surname>Maier</surname><given-names>J</given-names></name><name><surname>Kaiser</surname><given-names>PD</given-names></name><name><surname>Scholz</surname><given-names>AM</given-names></name><name><surname>Nueske</surname><given-names>S</given-names></name><name><surname>Buchfellner</surname><given-names>A</given-names></name><name><surname>Romer</surname><given-names>T</given-names></name><name><surname>Rothbauer</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Monitoring interactions and dynamics of endogenous beta-catenin with intracellular nanobodies in living cells</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>14</volume><fpage>707</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1074/mcp.M114.044016</pub-id><pub-id pub-id-type="pmid">25595278</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vigano</surname><given-names>MA</given-names></name><name><surname>Ell</surname><given-names>CM</given-names></name><name><surname>Kustermann</surname><given-names>MMM</given-names></name><name><surname>Aguilar</surname><given-names>G</given-names></name><name><surname>Matsuda</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>N</given-names></name><name><surname>Stasevich</surname><given-names>TJ</given-names></name><name><surname>Affolter</surname><given-names>M</given-names></name><name><surname>Pyrowolakis</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Protein manipulation using single copies of short peptide tags in cultured cells and in <italic>Drosophila melanogaster</italic> Development (Cambridge, England)</article-title><source>dev</source><volume>148</volume><elocation-id>e191700</elocation-id><pub-id pub-id-type="doi">10.1242/dev.191700</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virant</surname><given-names>D</given-names></name><name><surname>Traenkle</surname><given-names>B</given-names></name><name><surname>Maier</surname><given-names>J</given-names></name><name><surname>Kaiser</surname><given-names>PD</given-names></name><name><surname>Bodenhöfer</surname><given-names>M</given-names></name><name><surname>Schmees</surname><given-names>C</given-names></name><name><surname>Vojnovic</surname><given-names>I</given-names></name><name><surname>Pisak-Lukáts</surname><given-names>B</given-names></name><name><surname>Endesfelder</surname><given-names>U</given-names></name><name><surname>Rothbauer</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A peptide tag-specific nanobody enables high-quality labeling for dSTORM imaging</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>930</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-03191-2</pub-id><pub-id pub-id-type="pmid">29500346</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Tang</surname><given-names>NH</given-names></name><name><surname>Lara-Gonzalez</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Cheerambathur</surname><given-names>DK</given-names></name><name><surname>Prevo</surname><given-names>B</given-names></name><name><surname>Chisholm</surname><given-names>AD</given-names></name><name><surname>Desai</surname><given-names>A</given-names></name><name><surname>Oegema</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A toolkit for GFP-mediated tissue-specific protein degradation in <italic>C. elegans</italic> Development (Cambridge, England)</article-title><source>Dev</source><volume>144</volume><fpage>2694</fpage><lpage>2701</lpage><pub-id pub-id-type="doi">10.1242/dev.150094</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Meng</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>G</given-names></name><name><surname>Dong</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhan</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Regulation of olfactory-based sex behaviors in the silkworm by genes in the sex-determination cascade</article-title><source>PLOS Genetics</source><volume>16</volume><elocation-id>e1008622</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008622</pub-id><pub-id pub-id-type="pmid">32520935</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>N</given-names></name><name><surname>Colak-Champollion</surname><given-names>T</given-names></name><name><surname>Knaut</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>zGrad is a nanobody-based degron system that inactivates proteins in zebrafish</article-title><source>eLife</source><volume>8</volume><elocation-id>e43125</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.43125</pub-id><pub-id pub-id-type="pmid">30735119</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>N</given-names></name><name><surname>Kamijo</surname><given-names>K</given-names></name><name><surname>Fox</surname><given-names>PD</given-names></name><name><surname>Oda</surname><given-names>H</given-names></name><name><surname>Morisaki</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><name><surname>Stasevich</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A genetically encoded probe for imaging nascent and mature HA-tagged proteins in vivo</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>2947</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-10846-1</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74326.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>VijayRaghavan</surname><given-names>K</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03ht1xw27</institution-id><institution>National Centre for Biological Sciences, Tata Institute of Fundamental Research</institution></institution-wrap><country>India</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Rubin</surname><given-names>Gerald M</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/006w34k90</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Port</surname><given-names>Fillip</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cdgtt98</institution-id><institution>German Cancer Research Center (DKFZ) Heidelberg</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Protein visualization and manipulation in <italic>Drosophila</italic> through the use of epitope tags recognized by nanobodies&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and K VijayRaghavan as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Gerald M Rubin (Reviewer #1); Fillip Port (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>The revisions asked for concern matters of presentation and can hopefully be done speedily.</p><p><italic>Reviewer #1:</italic></p><p>This Tools and Resources paper makes a very significant contribution to the <italic>Drosophila</italic> toolbox by addressing the lack of multiple, well-characterized epitope/nanobody pairs for use in vivo and in vitro in <italic>Drosophila</italic>. Two new epitope/nanobody pairs and their characteristics are described in detail. These reagents, together with the previously described ALFA tag, fill the need for multiple independent epitope/nanobody pairs in experiments involving co-localization and other applications. The experiments are well-done, carefully documented and support the conclusions drawn. Methods for direct labelling of the nanobodies with fluorescent dyes are described, an important method for quantitative work. CRISPR-mediated knock-in of the tags into endogenous genes is also demonstrated. The nanobodies also work well in protein immunoblots and in biochemical purifications.</p><p>Page 1, line 29: the &quot;)&quot; after VHH05 should be a &quot;,&quot;.</p><p>Page 3, line 17-18: &quot;NbVHH05 (Ling et al., 2019) and Nb127D01&quot;. Bradley et al., 2015 reference should be inserted after Nb127D01.</p><p>In Figure 1: &quot;Mitochondrial&quot; should be replaced with &quot;Mitochondria&quot; in panels G and J. Why are the nuclei blue in color in Panel I? If DAPI stained, please say so and indicate which panels also included DAPI staining. In panel E, add to legend that the right most panel is GFP, the center panel is mCherry and the rightmost is a merged image.</p><p>In Figure 1, figure supplement 2: State size of scale bars in images.</p><p>Page 8, line 20: fluorophores (NbVHH05-555 and Nb127D01-647). Specify the identity of the fluorescent dyes used.</p><p>Page 8, line 28: It would help the reader if a one sentence explanation of sortase labeling was added here. Most readers will be unfamiliar with this method.</p><p>Page 8, line 30: Page 8, line 30: It would be more accurate to say &quot;highly&quot; than &quot;absolutely&quot; here.</p><p>Figure 2. Merged images appear to also have DAPI (or other nuclear) stain, but this is not mentioned in the legend.</p><p>Figure 2—figure supplement 1. Panels are mislabeled (A is really C). Define &quot;FT&quot; as flow thru.</p><p>Figure 2—figure supplement 3. &quot;Con-cell&quot; is a little cryptic. &quot;Mock transfected&quot; would be better.</p><p>Page 24 line 25: Please explain &quot;KI method&quot;. I think this is the first time the &quot;KI&quot; abbreviation is used.</p><p>Page 28, line 30: It was unclear to this reader what &quot;CB&quot; referred to. I had to go back thru the paper to find the definition. It would be better to spell it this location (the first sentence of the discussion).</p><p><italic>Reviewer #2:</italic></p><p>This work characterizes two nanobodies and the short peptide sequences they recognize for protein detection and manipulation in vitro and in vivo. Nanobodies are natural, short protein binders that can be genetically encoded and expressed in living cells, enabling many applications not feasible with conventional antibodies. Nanobodies that recognize short epitope tags have recently been described, but their number is currently limited. This work expands the repertoire of nanobody/nanotag pairs and demonstrates their usefulness in a large range of applications.</p><p>This paper is well written, the experiments are thoroughly designed and the data unambiguously support the conclusion that the two described nanobody/nanotag pairs are useful tools for cell and molecular biology. A particular strength of this study is the breadth of assays in which the authors test the described tools, ranging from in vitro assays such as Western blotting and immunoprecipitation to in vivo assays such as protein detection with fluorophore-tagged nanobodies or protein relocalization. Furthermore, the authors test a range of secondary reagents to detect unlabeled nanobodies and showcase how CRISPR genome engineering can be used to insert sequences encoding the nanotags into endogenous loci.</p><p>Going forward it will be important to better understand the specificity of the two nanobodies. Perfect matches of the corresponding nanotag sequences are not encoded in the <italic>Drosophila</italic> genome, as well as a range of other relevant genomes, but nanobodies might bind to endogenous proteins with imperfect sequence homology. The finding that nanobodies can be expressed in vivo without obvious fitness defects suggests that off-target binding is not prevalent, but does not exclude binding to specific targets. In the future it will therefore be important to more directly characterize potential endogenous binding partners of the two nanobodies. This could be done by immunoprecipitation of cell lysates followed by mass-spectrometry or by fusing nanobodies to a biotin ligase and expressing it in cells, followed by identification of biotinylated proteins.</p><p>Overall, this is a well-designed study that presents an exciting pair of tools that will be of broad interest to anyone interested in detecting and manipulating proteins in vitro, in cells or in living organisms.</p><p>Page 1; Line 29: (remove from VHH05)</p><p>The graphics that are provided alongside the figures are helpful to quickly grasp the experimental setup. However, they could be yet more intuitive if the used shapes adhered to common praxis. In particular, antibodies (e.g. Figure 2 C, D and others) should be depicted in their prototypical Y shape, rather than rectangular shapes.</p><p>Page 20, lines 23 – 38: The authors generate several constructs with the aim to check &quot;whether NanoTagged proteins can be detected in vivo&quot;. However, in the end only in vivo detection of Upd2 (and Dilp2 in a later figure) is reported. What happened to the constructs encoding tagged Akh, Dilp8, Pvf1 and Reptor-BP? Were they not tested in vivo?</p><p>Page 24, lines 2 – 6: Another common feature are the encoded NanoTags.</p><p>Page 29, line 19: The observation of protein aggregates should also be mentioned in the Results section when nanobody-GFP fusions are initially tested in S2R+ cells.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74326.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>The revisions asked for concern matters of presentation and can hopefully be done speedily.</p><p>Reviewer #1 (Recommendations for the authors):</p><p>Page 1, line 29: the &quot;)&quot; after VHH05 should be a &quot;,&quot;.</p></disp-quote><p>We fixed this mistake.</p><disp-quote content-type="editor-comment"><p>Page 3, line 17-18: &quot;NbVHH05 (Ling et al., 2019) and Nb127D01&quot;. Bradley et al., 2015 reference should be inserted after Nb127D01.</p></disp-quote><p>We added the reference as suggested.</p><disp-quote content-type="editor-comment"><p>In Figure 1: &quot;Mitochondrial&quot; should be replaced with &quot;Mitochondria&quot; in panels G and J. Why are the nuclei blue in color in Panel I? If DAPI stained, please say so and indicate which panels also included DAPI staining. In panel E, add to legend that the right most panel is GFP, the center panel is mCherry and the rightmost is a merged image.</p></disp-quote><p>Thank you for the suggestion. We replaced &quot;Mitochondrial&quot; with &quot;Mitochondria&quot; in panels G and J. We also added in the legend:</p><p>&quot;the right most panel is GFP, the center panel is mCherry, and the rightmost is the merged image. DAPI staining shows the nuclei &quot;.</p><disp-quote content-type="editor-comment"><p>In Figure 1, figure supplement 2: State size of scale bars in images.</p></disp-quote><p>We added &quot;Scale bars: 25 μm&quot; in the legend.</p><disp-quote content-type="editor-comment"><p>Page 8, line 20: fluorophores (NbVHH05-555 and Nb127D01-647). Specify the identity of the fluorescent dyes used.</p></disp-quote><p>Thank you for the comment. We replaced NbVHH05-555 and Nb127D01-647 with “NbVHH05-CF555 and Nb127D01-CF647” as suggested. In addition, we edited the other NbVHH05-555 prepared by sortase reaction as “NbVHH05-AF555”.</p><disp-quote content-type="editor-comment"><p>Page 8, line 28: It would help the reader if a one sentence explanation of sortase labeling was added here. Most readers will be unfamiliar with this method.</p></disp-quote><p>Thank you for the suggestion. We have added an explanation of the sortase labeling method. &quot;In addition, we used a fluorescent NbVHH05-AF555 prepared by site-specific Sortase labeling (Figure 2—figure supplement 2A3). For C-terminal Sortase-mediated labeling, the Sortase recognition motif (LPETG) is added to the C-terminus of the nanobody. Next, catalyzed by the Sortase, a fluorophore or biotin is added, using modified oligoglycine peptides such as GGG-fluorophore or GGG-biotin, to the nanobody-LPETG (<italic>Cheloha et al., 2019</italic>).&quot;</p><disp-quote content-type="editor-comment"><p>Page 8, line 30: Page 8, line 30: It would be more accurate to say &quot;highly&quot; than &quot;absolutely&quot; here.</p></disp-quote><p>We replaced &quot;absolutely&quot; with &quot;highly”.</p><disp-quote content-type="editor-comment"><p>Figure 2. Merged images appear to also have DAPI (or other nuclear) stain, but this is not mentioned in the legend.</p></disp-quote><p>We added &quot;DAPI staining shows the nuclei &quot; into the legend.</p><disp-quote content-type="editor-comment"><p>Figure 2—figure supplement 1. Panels are mislabeled (A is really C). Define &quot;FT&quot; as flow thru.</p></disp-quote><p>We revised the mislabeled panel and defined &quot;FT&quot; as Flow-Through in the legend.</p><disp-quote content-type="editor-comment"><p>Figure 2—figure supplement 3. &quot;Con-cell&quot; is a little cryptic. &quot;Mock transfected&quot; would be better.</p></disp-quote><p>We replaced the &quot;Con-cell&quot; with &quot;Mock transfected&quot;.</p><disp-quote content-type="editor-comment"><p>Page 24 line 25: Please explain &quot;KI method&quot;. I think this is the first time the &quot;KI&quot; abbreviation is used.</p></disp-quote><p>We replaced the &quot;KI method&quot; with &quot;knock-in (KI) method&quot;.</p><disp-quote content-type="editor-comment"><p>Page 28, line 30: It was unclear to this reader what &quot;CB&quot; referred to. I had to go back thru the paper to find the definition. It would be better to spell it this location (the first sentence of the discussion).</p></disp-quote><p>We replaced the &quot;CB&quot; with &quot;chromobodies (CBs)&quot;.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>Page 1; (Line 29: remove from VHH05)</p></disp-quote><p>We removed &quot;)&quot; as suggested.</p><disp-quote content-type="editor-comment"><p>The graphics that are provided alongside the figures are helpful to quickly grasp the experimental setup. However, they could be yet more intuitive if the used shapes adhered to common praxis. In particular, antibodies (e.g. Figure 2 C, D and others) should be depicted in their prototypical Y shape, rather than rectangular shapes.</p></disp-quote><p>Thank you for the suggestion. We changed the antibodies in Figure 2 C, D with Y shape.</p><disp-quote content-type="editor-comment"><p>Page 20, lines 23 – 38: The authors generate several constructs with the aim to check &quot;whether NanoTagged proteins can be detected in vivo&quot;. However, in the end only in vivo detection of Upd2 (and Dilp2 in a later figure) is reported. What happened to the constructs encoding tagged Akh, Dilp8, Pvf1 and Reptor-BP? Were they not tested in vivo?</p></disp-quote><p>We added “in vitro” in the sentence to clarify this point (“Next, we checked whether NanoTagged proteins can be detected in vitro and in vivo using purified nanobodies.”).</p><p>Originally, we chose Upd2 as an example for in vivo detection. In the meantime, we succeeded at generating transgenic REPTOR-bp-C flies and the staining results showed that NanoTagged Reptor-BP can be detected, which we added as new results in Figure 5—figure supplement 2.</p><disp-quote content-type="editor-comment"><p>Page 24, lines 2 – 6: Another common feature are the encoded NanoTags.</p></disp-quote><p>We modified the sentence (“Each vector contains five common features: the encoded NanoTags for N- or C-terminal tagging, …”).</p><disp-quote content-type="editor-comment"><p>Page 29, line 19: The observation of protein aggregates should also be mentioned in the Results section when nanobody-GFP fusions are initially tested in S2R+ cells.</p></disp-quote><p>As suggested, we now mention in the Results section: &quot;When either NbVHH05-GFP or Nb127D01-GFP was expressed in cells, we observed a GFP signal in the nucleus and the cytoplasm, although some S2R+ cells transfected with Nb127D01-GFP contained aggregates (Figure 1—figure supplement 2C,D).&quot;</p></body></sub-article></article>